<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80479</article-id><article-id pub-id-type="doi">10.7554/eLife.80479</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-309927"><name><surname>Li</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283046"><name><surname>Lou</surname><given-names>Xinqi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283047"><name><surname>Zha</surname><given-names>Yingjie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-304253"><name><surname>Qin</surname><given-names>Yinyin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283048"><name><surname>Zha</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283049"><name><surname>Hong</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283050"><name><surname>Xie</surname><given-names>Zhanli</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283051"><name><surname>Yang</surname><given-names>Shudi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283052"><name><surname>Wang</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-283053"><name><surname>An</surname><given-names>Jianzhong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-280791"><name><surname>Zhang</surname><given-names>Zhenhao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5659-6315</contrib-id><email>zhangzhh1@njmu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283054"><name><surname>Qiao</surname><given-names>Shigang</given-names></name><email>qiaos@njmu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05t8y2r12</institution-id><institution>Cyrus Tang Hematology Center, Soochow University</institution></institution-wrap><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/059gcgy73</institution-id><institution>Institute of Clinical Medicine Research, Suzhou Science &amp; Technology Town Hospital, Gusu School, Nanjing Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/059gcgy73</institution-id><institution>Faculty of Anesthesiology, Suzhou Science &amp; Technology Town Hospital, Gusu School, Nanjing Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ywvs716</institution-id><institution>Suzhou Polytechnic Institute of Agriculture</institution></institution-wrap><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Balasubramanyam</surname><given-names>Muthuswamy</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00czgcw56</institution-id><institution>Madras Diabetes Research Foundation</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e80479</elocation-id><history><date date-type="received" iso-8601-date="2022-05-22"><day>22</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-30"><day>30</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-07-01"><day>01</day><month>07</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.06.29.498129"/></event></pub-history><permissions><copyright-statement>© 2023, Li et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Li et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80479-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-80479-figures-v2.pdf"/><abstract><p>Myocardial fibrosis is the characteristic pathology of diabetes-induced cardiomyopathy. Therefore, an in-depth study of cardiac heterogeneity and cell-to-cell interactions can help elucidate the pathogenesis of diabetic myocardial fibrosis and identify treatment targets for the treatment of this disease. In this study, we investigated intercellular communication drivers of myocardial fibrosis in mouse heart with high-fat-diet/streptozotocin-induced diabetes at single-cell resolution. Intercellular and protein–protein interaction networks of fibroblasts and macrophages, endothelial cells, as well as fibroblasts and epicardial cells revealed critical changes in ligand–receptor interactions such as Pdgf(s)–Pdgfra and Efemp1–Egfr, which promote the development of a profibrotic microenvironment during the progression of and confirmed that the specific inhibition of the Pdgfra axis could significantly improve diabetic myocardial fibrosis. We also identified phenotypically distinct <italic>Hrc<sup>hi</sup></italic> and <italic>Postn<sup>hi</sup></italic> fibroblast subpopulations associated with pathological extracellular matrix remodeling, of which the <italic>Hrc<sup>hi</sup></italic> fibroblasts were found to be the most profibrogenic under diabetic conditions. Finally, we validated the role of the <italic>Itgb1</italic> hub gene-mediated intercellular communication drivers of diabetic myocardial fibrosis in <italic>Hrc<sup>hi</sup></italic> fibroblasts, and confirmed the results through AAV9-mediated <italic>Itgb1</italic> knockdown in the heart of diabetic mice. In summary, cardiac cell mapping provides novel insights into intercellular communication drivers involved in pathological extracellular matrix remodeling during diabetic myocardial fibrosis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>diabetic cardiomyopathy</kwd><kwd>liver fibrosis</kwd><kwd>retinal regeneration</kwd><kwd>rat</kwd><kwd>rabbit</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Suzhou Science and Technology Development Plan</institution></institution-wrap></funding-source><award-id>SKJY 2021038</award-id><principal-award-recipient><name><surname>Qiao</surname><given-names>Shigang</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Jiangsu Key Talent Youth Awards in Medicine</institution></institution-wrap></funding-source><award-id>QNRC2016219</award-id><principal-award-recipient><name><surname>Qiao</surname><given-names>Shigang</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Gusu Health Youth Talent Awards</institution></institution-wrap></funding-source><award-id>GSWS2019092</award-id><principal-award-recipient><name><surname>Qiao</surname><given-names>Shigang</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Gusu Health Talent Program</institution></institution-wrap></funding-source><award-id>GSWS2021068</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Zhenhao</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Suzhou New District Science and Technology Project</institution></institution-wrap></funding-source><award-id>2020Z007</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Zhenhao</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>General Program of Basic Science in Jiangsu Higher Education Institutions</institution></institution-wrap></funding-source><award-id>21KJB350017</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Shudi</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>the Core Medical Science Subjects in Suzhou</institution></institution-wrap></funding-source><award-id>SZXK202131</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Shudi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cardiac intercellular communication plays a critical role in diabetic myocardial fibrosis and specific targeting of Hrc<sup>hi</sup> fibroblasts may be a potential therapeutic target for diabetic cardiomyopathy.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Diabetes is the third most common threat to human health, approximately 537 million adults living with diabetes, of which type 2 diabetes patients account for more than 90% of all diabetic patients. Cardiac complications are the most common causes of death and disability associated with diabetes. As the key initiating factor of diabetic cardiomyopathy, hyperglycemia can prevent optimal utilization of glucose by cardiomyocytes, which leads to myocardial fibrosis. Myocardial fibrosis is characterized by the increase in extracellular matrix proteins, deposition of interstitial collagen, disarrangement of cardiomyocytes, and the remodeling of cardiac structure (<xref ref-type="bibr" rid="bib49">Russo and Frangogiannis, 2016</xref>; <xref ref-type="bibr" rid="bib23">Jia et al., 2018</xref>). Since adult mammalian cardiomyocytes are incapable of regeneration, the most extensive pathological extracellular matrix remodeling and fibrosis occur during various heart diseases caused by cardiomyocyte death (<xref ref-type="bibr" rid="bib28">Kong et al., 2014</xref>). Understanding the mechanisms responsible for myocardial fibrosis is critical to develop anti-fibrotic therapy strategies for diabetic patients.</p><p>Mammalian hearts consist of many cell types, including cardiomyocytes, macrophages, fibroblasts and endothelial cells, etc. (<xref ref-type="bibr" rid="bib5">Banerjee et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Litviňuková et al., 2020</xref>). Cell-to-cell communication is a fundamental feature of adult complex organs. These different types of cells communicate through interactions with ligand–receptor, where a ligand may be secreted and bind to a receptor, or through the fusion of two adjacent interacting cell membranes (<xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>). The maintenance of heart homeostasis depends on intercellular communication (<xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>). Many ligand–receptor signaling patterns have been identified between cardiac cells, indicating the critical role of intercellular communication in many pathophysiological processes. Therefore, intercellular communication has become a powerful therapeutic target for prevention or reversion of some of the damaging consequences of diabetic myocardial fibrosis by maintaining fine-tuned intercellular communication among different cardiac cells. Despite these findings, the overall effect of diabetes on cardiac intercellular communication and myocardial fibrosis remains poorly understood.</p><p>Single-cell RNA sequencing (scRNA-seq) is a feasible strategy for studying the cellular heterogeneity of any organ since it allows transcriptomic profiling of individual cells (<xref ref-type="bibr" rid="bib6">Butler et al., 2018</xref>; <xref ref-type="bibr" rid="bib16">Gladka et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Litviňuková et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>). Recent scRNA-seq of many tissues has revealed cellular heterogeneity and novel intercellular crosstalk among different cell types. In this study, we developed a diabetic mouse model through high-fat diet (HFD) combined with streptozotocin (STZ) administration, and identified the composition of all cardiac cells, cellular subpopulations associated with diabetic cardiomyopathy, enrichment of signaling pathways involved in myocardial fibrosis, alterations of key ligand–receptor interactions and the most profibrotic <italic>Hrc<sup>hi</sup></italic> fibroblast subcluster in mouse hearts using scRNA-seq on a 10× genomics platform. Our study suggests that cardiac intercellular communication plays a critical role in diabetic myocardial fibrosis and specific targeting of <italic>Hrc<sup>hi</sup></italic> fibroblasts may be a potential therapeutic target for this cardiac disease.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell profile of heart in diabetic mice</title><p>Conventional single-cell RNA-seq does not cover all cells in the rodent myocardium for subsequent deep sequencing (<xref ref-type="bibr" rid="bib54">Skelly et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Forte et al., 2020</xref>). Therefore, we isolated the nuclear fractions of all cardiac cells to assess the heterogeneity of cell populations and changes in the transcriptional profile in response to the pathology of HFD/STZ-induced diabetes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib19">Grindberg et al., 2013</xref>; <xref ref-type="bibr" rid="bib1">Ackers-Johnson et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Lake et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>). We classified 32,585 cardiac cells from 6 healthy controls (16,490 cells) and 6 HFD/STZ-induced diabetic mice (16,095 cells) into 25 transcriptionally distinct pre-clusters that exhibited highly consistent expression patterns across individual mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), and identified 14 populations (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) based on cell-specific markers and significantly enriched genes. The cell populations included fibroblasts (<italic>Pdgfra</italic>, <italic>Pcdh9</italic>, <italic>Bmper</italic>), endothelial cells (<italic>Pecam1</italic>, <italic>Ccdc85a</italic>, <italic>Btnl9</italic>), macrophages (<italic>Fcgr1</italic>, <italic>F13a1</italic>, <italic>Adgre1</italic>), pericytes (<italic>Pdgfrb</italic>, <italic>Vtn</italic>, <italic>Trpc3</italic>), adipocytes (<italic>Adipoq</italic>, <italic>Plin1</italic>, <italic>Tshr</italic>), cardiomyocytes (<italic>Ttn</italic>, <italic>Mhrt</italic>, <italic>Myh6</italic>), smooth muscle cells (<italic>Acta2</italic>, <italic>Myh11</italic>, <italic>Cdh6</italic>), endocardial cells (<italic>Npr3</italic>, <italic>Tmem108</italic>, <italic>Plvap</italic>), epicardial cells (<italic>Msln</italic>, <italic>Pcdh15</italic>, <italic>Muc16</italic>), schwan cells (<italic>Plp1</italic>, <italic>Gfra3</italic>), and other immune cell populations (T cells, monocytes, B cells) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Based on cell types, markers, and relative proportions, we concluded that our data were robust and consistent with previous 10× single nucleus data from mice heart (<xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>). Further examination of established marker genes in each cardiac cell population revealed the presence of a wide range of cell types in all analyzed hearts (<xref ref-type="fig" rid="fig1">Figure 1C, D</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell profile of heart in diabetic mice.</title><p>(<bold>A</bold>) t-SNE projection of all mouse cardiac cells (<italic>n</italic> = 16,490 cardiac cells from 6 control mice and <italic>n</italic> = 16,095 cardiac cells from 6 diabetic mice). (<bold>B</bold>) The marker genes defining each type of cell cluster in A are listed. (<bold>C</bold>) Heatmap showings the canonical cell markers of major cardiac cell populations. (<bold>D</bold>) Dot plot representing the top 5 distinct genes in each cell population. (<bold>E</bold>) Lollipop plot showing the number of up- and downregulated genes in high-fat diet (HFD)/streptozotocin (STZ)-treated mouse heart cells, compared with the control. Adipo, adipocytes; Cardio, cardiomyocytes; Endocar, endocardial cells; EC, endothelial cells; Epicar, epicardial cells; Fibro, fibroblasts; LEC, lymphatic ECs; Mono, monocytes; Schwann, schwann cells; SMC, smooth muscle cells; Macro, macrophages; Peri, pericytes; Details of the 25 transcriptionally distinct pre-clusters with highly consistent expression patterns across individual mouse heart are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Detailed genes with significant transcriptomic changes in cardiac populations are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The details of top 10 upregulated genes in cardiac populations are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Experimental design and cell type characterization.</title><p>(<bold>A</bold>) Schematic overview of the experimental design. (<bold>B</bold>) t-SNE projection of all pre-clustered cells (<italic>n</italic> = 16,490 cardiac cells from 6 control mice and <italic>n</italic> = 16,095 cardiac cells from 6 diabetic mice).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>The top 10 upregulated genes during the pathology of high-fat diet (HFD)/streptozotocin (STZ)-induced diabetes within each cell population.</title><p>The circle size illustrates the proportion of cells within each transcript, while the dot color indicates the relative average expression level of the gene.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Top 30 enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in high-fat diet (HFD)/streptozotocin (STZ)-treated mouse fibroblasts.</title><p>The plot shows top 30 enriched KEGG pathways in HFD/STZ-treated mouse fibroblasts relative to control (two-sided Wilcoxon rank-sum test, false discovery rate (FDR ≤0.05).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig1-figsupp3-v2.tif"/></fig></fig-group><p>HFD/STZ treatment induced significant transcriptomic changes in most cardiac populations, especially in fibroblasts, endothelial cells, endocardial cells, cardiomyocytes and macrophages (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2 and</xref> two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36). Analysis of the top 10 upregulated genes during the pathology of HFD/STZ-induced diabetes within each cell population showed that some of the top 10 upregulated genes show a noticeable increase in expression across many different cell types, even though some are primarily expressed in only one cell type (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref> and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Among the top upregulated genes in response to HFD/STZ-induced diabetes within each cell population were transcripts for <italic>Pdk4</italic>, <italic>Angptl4</italic>, <italic>Txnip</italic>, <italic>Postn</italic>, <italic>Hmgcs2</italic>, and <italic>Ucp3</italic>, of which several have been previously involved in heart failure (<xref ref-type="bibr" rid="bib61">Yoshioka et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Lang et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Sheeran et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>). The top 30 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways within fibroblast population were associated with dilated cardiomyopathy, cardiac muscle contraction, and hypertrophic cardiomyopathy (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>, two-sided Wilcoxon rank-sum test, FDR ≤0.05). These results indicate a significantly increased risk of cardiovascular diseases in a diabetic setting.</p><p>Taken together, scRNA-seq identified distinct cell populations in the mouse heart that can help characterize HFD/STZ-induced diabetes-related changes based on gene expression and quantify gene–trait associations.</p></sec><sec id="s2-2"><title>Effects of HDF/STZ-induced diabetes on cardiac intercellular communication</title><p>Cell subpopulations with non-overlapping functions present distinct transcriptomic perturbations in response to pathological stimuli (<xref ref-type="bibr" rid="bib38">Mathys et al., 2019</xref>). To determine whether distinct cardiac cell populations respond heterogeneously to diabetic stimuli, we compared differentially expressed genes in all cardiac cell types and identified 2118 unique differentially expressed genes (uni-DEGs) associated with each of the major cardiac cell types (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Most of the uni-DEGs (96.6%) were detected in cardiomyocytes (32.8%), fibroblasts (18.5%), macrophages (17.7%), endothelial cells (19.7%), and endocardial cells (7.9%). The genes that were most highly expressed in only a single-cell type were <italic>Gm20658</italic> (fibroblasts), <italic>Ucp3</italic> (cardiomyocytes), <italic>Spock2</italic> (endocardial cells), <italic>Irf7</italic> (endothelial cells), and <italic>Ifi206</italic> (macrophages), of which <italic>Ucp3</italic> and <italic>Irf7</italic> were involved in heart failure and pathological cardiac hypertrophy (<xref ref-type="bibr" rid="bib24">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Senatus et al., 2020</xref>). However, the association of <italic>Gm20658</italic>, <italic>Spock2</italic> and <italic>Ifi206</italic> with myocardial fibrosis or heart failure has not been previously reported. Gene Ontology (GO) analysis of the uni-DEGs (upregulated) showed that terms associated with collagen fibril organization and extracellular matrix remodeling were enriched in the cardiac fibroblasts (<xref ref-type="fig" rid="fig2">Figure 2A</xref> , two-sided Wilcoxon rank-sum test, FDR ≤0.05), indicating that fibroblasts are key cellular contributors to extracellular matrix remodeling and cardiac fibrosis.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Comparison analysis of the communications between cardiac cells during high-fat diet (HFD)/streptozotocin (STZ)-induced diabetes.</title><p>(<bold>A</bold>) Heatmap showing the enriched Gene Ontology (GO) terms associated with extracellular matrix remodeling and myocardial fibrosis in major cardiac cell populations in the diabetic group. (<bold>B</bold>) The relative expression of selected essential growth factors in the major cardiac cell types. (<bold>C</bold>) Heatmap showings the number of ligand–receptor pairs between cardiac cell populations in healthy mice. (<bold>D</bold>) Heatmap shows the number of ligand–receptor pairs between cardiac cell populations in the HFD/STZ-induced diabetic mice. (<bold>E</bold>) Bar plot shows total number of connections made by each cell type without (gray bars) and with HFD/STZ treatment (red bars). (<bold>F</bold>) Bar plot illustrates the number of upregulated receptors and ligands for each population of cardiac cells. (<bold>G</bold>) Bar plot showing the number of downregulated receptors and ligands in each cardiac cell population. DB, diabetes. The details of unique differentially expressed genes (uni-DEGs) in the cardiac populations are listed in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. The details of significantly differentially expressed genes in the specific cell populations relative to others in mouse heart are listed in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. Details of cell type-specific receptors in the cardiac populations and cell type-specific ligands in cardiac populations are listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> and <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>, respectively. The details of relative expression of a selection of essential growth factors across major cardiac cell types are listed in <xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>. The details of the number of ligand–receptor pairs between cardiac cell populations in healthy mice or diabetic mice are listed in <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref> and <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>, respectively. The details of significantly differentially expressed ligands and receptors in each cell population are listed in <xref ref-type="supplementary-material" rid="supp11">Supplementary file 11</xref> and <xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref>, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The expression of receptors and ligands across major cardiac cell types.</title><p>The heatmap shows the relative expression of receptors (<bold>A</bold>) and ligands (<bold>B</bold>) across the major cardiac cell populations (FDR ≤0.01, log2FC ≥1).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig2-figsupp1-v2.tif"/></fig></fig-group><p>The proper functioning of metazoans is tightly controlled by intercellular communication between multiple cell populations, which is based on interactions between secretory ligands and receptors (<xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>). To determine the effect of HFD/STZ-induced diabetes on cardiac intracellular communication, we mapped the intercellular connection network of the cardiac cellulome in healthy controls and diabetic mice. Initially, we identified genes that were differentially expressed in specific cell populations in the mouse heart, focusing on those that were overexpressed in a single-cell type, that is, specific highly expressed genes, at FDR ≤0.01 with a minimum twofold difference in expression (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). The gene expression patterns for receptors and ligands were found to be cell type specific in the heart secretome genes analyzed through clustering (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). Analysis of the factors that support the growth of specific cell populations revealed critical intercellular communication channels. These include signaling pathways that support the survival of specific cell populations of the mouse hearts (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>). For example, pericytes and fibroblasts express <italic>Il34</italic> and <italic>Csf1</italic>, respectively (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), and communicate through <italic>Csf1r</italic>, while functioning as key factors for macrophage survival and growth. Fibroblasts also express <italic>Igf1</italic> and <italic>Ngf</italic> (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), which support the growth of endothelial cells, mural cells, and neurons (<xref ref-type="bibr" rid="bib17">Glebova and Ginty, 2004</xref>; <xref ref-type="bibr" rid="bib3">Bach, 2015</xref>). To construct a map of intercellular signaling among heart cells using scRNA-seq data, we integrated them with a ligand–receptor interaction database (<xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>). The results showed that the endothelial and fibroblast clusters are prominent hubs for autocrine and paracrine signaling (<xref ref-type="fig" rid="fig2">Figure 2C, D</xref>, <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>, <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>, FDR ≤0.01, log2FC ≥1), and that intercellular signaling in response to HFD/STZ-induced diabetes had changed in all cardiac cells, with fibroblasts showing the greatest increase in the number of connections (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>, <xref ref-type="supplementary-material" rid="supp11">Supplementary file 11</xref>, <xref ref-type="supplementary-material" rid="supp12">Supplementary file 12</xref> and two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36). Together, the results of these analyses suggest that intercellular communications play an important role in the alterations of cardiac microenvironment of diabetic mice.</p></sec><sec id="s2-3"><title>Identification of key ligand–receptor pairs associated with diabetic myocardial fibrosis in fibroblasts</title><p>Cardiac fibroblasts are the primary drivers of myocardial fibrosis (<xref ref-type="bibr" rid="bib58">Travers et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Frangogiannis, 2021</xref>). Given the result that cardiac fibroblasts cause the greatest increase in the number of connections in response to HFD/STZ-induced diabetes, perturbations of intercellular communications between cardiac fibroblasts and cardiac populations may be key drivers of diabetic myocardial fibrosis. To investigate the key receptor–ligand interactions in diabetic myocardial fibrosis, highly expressed receptors in cardiac fibroblasts were screened (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, FDR ≤0.01, log2FC ≥1). Then, we merged the upregulated uni-DEGs in the fibroblasts and the highly expressed fibroblast receptors, whose cognate ligands were upregulated in at least one cardiac cell type during diabetic progression (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). A protein–protein interaction (PPI) network was constructed using the new fibroblast-specific gene set (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). <italic>Egfr</italic> and <italic>Pdgfra</italic> were among the top hub genes based on the node degree that were specifically high-expressed receptors in the cardiac fibroblasts (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C</xref>). To clarify their role in fibrotic progression, we screened for the cognate ligands of <italic>Egfr</italic> and <italic>Pdgfra</italic> in each cardiac cell population (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A, B</xref>, <xref ref-type="supplementary-material" rid="supp13">Supplementary file 13</xref>, and <xref ref-type="supplementary-material" rid="supp14">Supplementary file 14</xref>). Both <italic>Pdgfb</italic> and <italic>Pdgfd</italic> transcripts were upregulated in endothelial cells, while <italic>Pdgfc</italic> levels were significantly elevated in the macrophages of diabetic mice (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref> and two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36). The protein levels of Pdgfb, Pdgfd, and Pdgfc showed similar changes in the corresponding cardiac cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D–F</xref>, <italic>n</italic> = 6 mice per group). In addition, the <italic>Egfr</italic> ligand <italic>Efemp1</italic> was upregulated in the epicardial cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref> and two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36). These results suggest that the interactions between cardiac fibroblasts with endothelial cells, macrophages and epicardial cells through Pdgf(s)–Pdgfra and Efemp1–Egfr may contribute to myocardial fibrosis in the diabetic mouse heart.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Identification of key ligand–receptor pairs associated with diabetic myocardial fibrosis in the fibroblasts.</title><p>(<bold>A</bold>) Heatmap showing the pairs of highly expressed fibroblast receptors and upregulated ligands in each cell type in the diabetic hearts. (<bold>B</bold>) PPI network showing the interactions of the upregulated genes in the fibroblasts. The circle size represents the protein node degree in the network. Volcano plots of the DEGs in the heart tissues of high-fat diet (HFD)/streptozotocin (STZ)-treated and control mice. <italic>Pdgfa</italic>, <italic>Pdgfb</italic>, <italic>Pdgfc</italic>, and <italic>Pdgfd</italic> expression in the endothelial cells (<bold>C</bold>) and macrophages (<bold>D</bold>) are highlighted. (<bold>E</bold>) Volcano plots of the DEGs in the hearts of the HFD/STZ-treated and control mice. <italic>Efemp1</italic> expression in the epicardial cells is highlighted. (<bold>F</bold>) Representative immunofluorescence images of p-Pdgfra in the heart tissues of the HFD/STZ-treated mice with or without Ima treatment (<italic>n</italic> = 6 mice per group), scale bar = 40 µm. Bar plots showing mRNA expression of <italic>Col1a1</italic> (<bold>G</bold>) and <italic>Col3a1</italic> (<bold>H</bold>) in the heart tissues of the HFD/STZ-treated mice with or without Ima treatment (<italic>n</italic> = 6 mice per group; mean ± SEM; **p &lt; 0.01; ***p &lt; 0.001). (<bold>I</bold>) Representative images of Masson dye-stained heart sections from the groups indicated showing the extent of collagen deposition (<italic>n</italic> = 6 mice per group), scale bar = 20 µm. Ima, imatinib mesylate; SEM, standard error of mean. The details of the cognate ligands of <italic>Egfr</italic> and <italic>Pdgfra</italic> are listed in <xref ref-type="supplementary-material" rid="supp13">Supplementary file 13</xref> and <xref ref-type="supplementary-material" rid="supp14">Supplementary file 14</xref>, respectively.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for CT values of <italic>Col</italic>1a1 used for <xref ref-type="fig" rid="fig3">Figure 3G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-80479-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data for CT values of <italic>Col</italic>3a1 used for <xref ref-type="fig" rid="fig3">Figure 3H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-80479-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Identification of key ligand–receptor pairs associated with diabetic myocardial fibrosis in the fibroblasts.</title><p>(<bold>A</bold>) Dot plot showing the high expression of specific receptors in the cardiac cell populations. The circle size indicates the proportion of cells within the groups that express each transcript. The red and blue dots indicate up- and downregulated genes, respectively. Two-dimensional t-SNE projection of <italic>Pdgfra</italic> (<bold>B</bold>) and <italic>Egfr</italic> (<bold>C</bold>) expression in the cardiac cell populations. Green and gray colors indicate up- and downregulated genes, respectively. Representative immunofluorescence images of Pdgfb (<bold>D</bold>) and Pdgfc (<bold>E</bold>) in the CD31<sup>+</sup> cells, and Pdgfd (<bold>F</bold>) in the CD68<sup>+</sup> cells in the heart tissues of high-fat diet (HFD)/streptozotocin (STZ)-treated and control mice (<italic>n</italic> = 6 mice per group), scale bar = 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>The cognate ligands of <italic>Egfr</italic> in each cardiac cell population.</title><p>(<bold>A</bold>) Dot plot showing the cognate ligands of <italic>Egfr</italic> in each cardiac cell population. (<bold>B</bold>) Dot plot showing the cognate ligands of <italic>Pdgfra</italic> in each cardiac cell population. The circle size indicates the proportion of cells within groups that express each transcript. The red and blue dots indicate up- and downregulated genes, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Immunofluorescence results of Pdgfb, Pdgfc, and Pdgfd in the Pdgfra<sup>+</sup> cells.</title><p>Representative immunofluorescence images for Pdgfb (<bold>A</bold>), Pdgfc (<bold>B</bold>), and Pdgfd (<bold>C</bold>) in Pdgfra<sup>+</sup> cells in the heart tissues of high-fat diet (HFD)/streptozotocin (STZ)-treated and control groups (<italic>n</italic> = 6 mice per group), scale bar = 40 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Assessment of myocardial hypertrophy using by WGA staining.</title><p>(<bold>A</bold>) Representative heart WGA staining using tissues from high-fat diet (HFD)/streptozotocin (STZ)-treated mice with or without Ima treatment (<italic>n</italic> = 6 mice per group), scale bar = 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Echocardiographic evaluation of mice heart function.</title><p>(<xref ref-type="fig" rid="fig1">Figure 1</xref>) Left ventricular ECG representative images of the control, diabetic and Ima treatment mice. (Table 1) ECG assessment of heart function in each different group.</p><p><supplementary-material id="fig3s5sdata1"><label>Figure 3—figure supplement 5—source data 1.</label><caption><title>Source data files are provided to support Table 1 in <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-80479-fig3-figsupp5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig3-figsupp5-v2.tif"/></fig></fig-group><p>Pdgfra exerts its tyrosine kinase activity by binding to its cognate ligands. Immunostaining of cardiac tissue revealed significantly higher protein levels of Pdgfb, Pdgfc, and Pdgfd in the Pdgfra-positive cells of the diabetic group (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–C</xref>, <italic>n</italic> = 6 mice per group). To examine the functional role of Pdgfra in diabetic myocardial fibrosis, we treated the HFD/STZ-induced diabetic mice with the Pdgfra inhibitor imatinib mesylate (Ima). The results showed that HFD/STZ treatment significantly increased cardiac p-Pdgfra protein levels and decreased that of p-Pdgfra in the HFD/STZ + Ima group compared with the HFD/STZ group (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <italic>n</italic> = 6 mice per group). In addition, the myocardium of the HFD/STZ-treated mice expressed higher levels of <italic>Col1a1</italic> and <italic>Col3a1</italic> compared with the control group (<xref ref-type="fig" rid="fig3">Figure 3G, H</xref>, <italic>n</italic> = 6 mice per group, mean ± standard error of mean [SEM], **p &lt; 0.01, ***p &lt; 0.001), which coincided with increased collagen deposition in the extracellular matrix. However, Ima treatment attenuated the increase in HFD/STZ-induced collagen synthesis and deposition (<xref ref-type="fig" rid="fig3">Figure 3I</xref>, <italic>n</italic> = 6 mice per group). Next, we performed WGA staining to assess myocardial hypertrophy in mice. The myocardial hypertrophy of HFD/STZ diabetic mice was improved significantly after Ima treatment (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>, <italic>n</italic> = 6 mice per group). Finally, we evaluated the improvement of heart function in diabetic mice after Ima treatment using echocardiography (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>, <italic>n</italic> = 15 mice per group, mean ± standard deviation; *p &lt; 0.01; **p &lt; 0.01; ***p &lt; 0.001). As shown in the <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>, Ima treatment significantly improved the LV function of the diabetic mice as evaluated using IVSs, EF, FS, LV mass, and the E/A ratio. Taken together, our results show that Pdgf(s)–Pdgfra interactions contribute to diabetic myocardial fibrosis.</p></sec><sec id="s2-4"><title>Identification of myocardial fibrosis-related cardiac fibroblast subpopulation</title><p>Cell subpopulations in the tissues perform non-overlapping functions and play different biological roles (<xref ref-type="bibr" rid="bib11">Croft et al., 2019</xref>). Cell types can be defined by the unbiased clustering of single cells based on global transcriptome patterns (<xref ref-type="bibr" rid="bib47">Rozenblatt-Rosen et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>). To observe the heterogeneity of fibroblasts in the heart, we examined 6416 fibroblasts from the diabetes and control mice. Unsupervised Seurat-based clustering of the 6416 fibroblasts revealed 10 distinct subpopulations (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>, and <italic>n</italic> = 3428 fibroblasts from healthy control and <italic>n</italic> = 2988 fibroblasts from 6 diabetic mice). Next, hierarchical clustering with multiscale bootstrap resampling was used to analyze the heterogeneity of these cardiac fibroblast subpopulations. The analysis revealed that fibroblast subpopulation 3 formed a distinct cluster from other fibroblast subpopulations, based on its expression pattern (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Analysis of the heterogeneity of the fibroblast subpopulations.</title><p>(<bold>A</bold>) t-SNE plot of the 10 cardiac fibroblast subpopulations in the high-fat diet (HFD)/streptozotocin (STZ)-treated and control mice (<italic>n</italic> = 3428 fibroblasts from healthy control and <italic>n</italic> = 2988 fibroblasts from 6 diabetic mice). (<bold>B</bold>) Correlation heatmap of the gene-expression signatures of each fibroblast subpopulation. Color differences indicate subpopulations that were resolved through multiscale bootstrapping. (<bold>C</bold>) Heatmap showing the top 5 marker genes in each fibroblast subpopulation. The red color indicates high expression, while green color indicates low expression. (<bold>D</bold>) Heatmap showing the enriched Gene Ontology (GO) terms associated with cardiac fibrosis in each fibroblast population. (<bold>E, F</bold>) Representative immunofluorescence images of Hrc (<bold>E</bold>) and Postn (<bold>F</bold>) in mouse heart (<italic>n</italic> = 6 mice per group), scale bar = 100 µm. The details of the 10 transcriptionally distinct fibroblast subpopulations are listed in <xref ref-type="supplementary-material" rid="supp15">Supplementary file 15</xref>. The details of distinct signatures of each fibroblast subpopulation in the heart are listed in <xref ref-type="supplementary-material" rid="supp16">Supplementary file 16</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig4-v2.tif"/></fig><p>We further investigated the contribution of all fibroblast populations to myocardial fibrosis. The top 5 ranking markers in the heart showed distinct signatures for each subpopulation of fibroblasts using heatmap analysis (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="supp16">Supplementary file 16</xref>, FDR ≤0.05, log2FC ≥0.36). It is worthy to note that the top enriched genes in subpopulation 3 (<italic>Nppa</italic> and <italic>Clu</italic>) and subpopulation 5 (<italic>Postn</italic> and <italic>Cilp</italic>) are well-established biomarkers of pro-fibrotic function. The gene set variation analysis (GSVA) of each fibroblast subpopulation suggested a diversification of function between the subpopulations, and fibroblast 3 and 5 populations were strongly involved in extracellular matrix remodeling and collagen synthesis (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, FDR ≤0.05). These results indicate that fibroblast 3 and 5 subpopulations are myocardial fibrosis-related cardiac fibroblast subpopulations.</p><p>The most significantly enriched gene in subpopulation 3 was <italic>Hrc</italic>, which is crucial for proper cardiac function through the regulation of Ca<sup>2+</sup>-uptake, storage, and release. The most significantly enriched gene in fibroblast subpopulation 5 was <italic>Postn</italic>, which is consistent with the fibroblast subset identified in an animal model of angiotensin-induced myocardial hypertrophy (<xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>). The <italic>Hrc<sup>hi</sup></italic> and <italic>Postn<sup>hi</sup></italic> fibroblast populations were also detected in mouse heart by immunostaining for Hrc and Postn, respectively (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>, <italic>n</italic> = 6 mice per group).</p></sec><sec id="s2-5"><title>Transcription factor network analysis</title><p>To investigate the underlying molecular mechanisms that drive the phenotypic differentiation of the fibroblast subpopulations, we used single-cell regulatory network inference and clustering. The results revealed the upregulation of different transcription factor networks in each subpopulation. For instance, <italic>Thra</italic> and <italic>Creb5</italic> regulons were upregulated in fibroblast subpopulation 0 and 2, respectively, whereas the <italic>Nfe2l1</italic> network was enriched in subpopulation 3, while subpopulation 4 showed the increased activation of the <italic>Foxp2</italic> network (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="supp17">Supplementary file 17</xref>). Regulons driven by <italic>Tcf4</italic> transcription factors were enriched in subpopulations 1 and 9, while <italic>Mef2a</italic> was enriched in subpopulations 7 and 8. Consistent with the role of <italic>Hmgb1</italic> in cardiac fibrosis (<xref ref-type="bibr" rid="bib60">Wu et al., 2018</xref>), a <italic>Hmgb1</italic>-based network was upregulated in the <italic>Hrc<sup>hi</sup></italic> and <italic>Postn<sup>hi</sup></italic> fibroblast populations (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Heatmap analysis further confirmed the upregulation of transcription factors (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="supplementary-material" rid="supp18">Supplementary file 18</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Transcription factor network analysis of fibroblast subpopulations.</title><p>(<bold>A</bold>) Heatmap shows the inferred transcription factor gene-regulatory networks. Numbers between brackets indicate the (extended) regulons for respective transcription factors. (<bold>B</bold>) Heatmap shows the expression level of transcription factors in (<bold>A</bold>). The details of transcription factor gene-regulatory networks in the distinct subpopulations are listed in <xref ref-type="supplementary-material" rid="supp17">Supplementary file 17</xref>. The details of the transcription factors expression are listed in <xref ref-type="supplementary-material" rid="supp18">Supplementary file 18</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig5-v2.tif"/></fig></sec><sec id="s2-6"><title>Identification of intercellular communication drivers of myocardial fibrosis in the <italic>Hrc<sup>hi</sup></italic> fibroblasts</title><p>To identify the cellular drivers of myocardial fibrosis during diabetes, we performed a cluster analysis of the DEGs between control and diabetic mice heart. HFD/STZ treatment induced transcriptional changes in all cardiac fibroblast subpopulations (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp19 supp2">Supplementary files 19</xref>, and two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36), and the upregulated genes in the <italic>Hrc<sup>hi</sup></italic> fibroblasts were enriched in GO terms such as collagen fiber reorganization and extracellular matrix binding (<xref ref-type="fig" rid="fig6">Figure 6A</xref> and two-sided Wilcoxon rank-sum test, FDR ≤0.05). Furthermore, the top 20 enriched pathways in the <italic>Hrc<sup>hi</sup></italic> fibroblasts of the diabetic group were associated with extracellular matrix organization, myocardial fibrosis, and fibroblast activation (<xref ref-type="fig" rid="fig6">Figure 6B</xref> and two-sided Wilcoxon rank-sum test, FDR ≤0.05). These results suggest that the <italic>Hrc<sup>hi</sup></italic> fibroblasts are key cellular drivers of myocardial fibrosis in response to HFD/STZ-induced diabetes.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Identification of intercellular communication drivers of myocardial fibrosis in the <italic>Hrc<sup>hi</sup></italic> fibroblasts.</title><p>(<bold>A</bold>) Heatmap showing high-fat diet (HFD)/streptozotocin (STZ)-induced enrichment of Gene Ontology (GO) terms associated with extracellular matrix remodeling and myocardial fibrosis in each subpopulation of cardiac fibroblasts. (<bold>B</bold>) Dot plot of the GO analysis showing the top 20 terms with the highest enrichment in the <italic>Hrc<sup>hi</sup></italic> fibroblasts of the HFD/STZ-treated mice relative to controls. (<bold>C</bold>) PPI network showing the interactions of the upregulated genes in the <italic>Hrc<sup>hi</sup></italic> fibroblasts of diabetic mice relative to controls. The circle size represents the protein node degree in the network. (<bold>D</bold>) Representative immunofluorescence images of Itgb1 in the heart of SHH-fed or control mice (<italic>n</italic> = 6 mice per group). scale bar = 40 µm. (<bold>E</bold>) Volcano plots showing the DEGs in the heart tissues of the HFD/STZ-treated or control mice with <italic>Fn1</italic> and <italic>Lgals3bp</italic> highlighted. Representative immunofluorescence images for Fn1 (<bold>F</bold>) and Lgals3bp (<bold>G</bold>) in the mouse heart (<italic>n</italic> = 6 mice per group), scale bar = 100 µm. (<bold>H</bold>) The efficiency of siRNA-mediated <italic>Itgb1</italic> mRNA knockdown was confirmed by qRT–PCR (<italic>n</italic> = 6 mice per group, mean ± standard error of mean [SEM], ****p &lt; 0.0001). (<bold>I</bold>) Representative images of Masson dye-stained heart sections from the indicated groups showing extent of collagen deposition (<italic>n</italic> = 6 mice per group), scale bar = 20 µm. Detailed genes of significant transcriptomic changes in each fibroblast subpopulation are listed in <xref ref-type="supplementary-material" rid="supp19">Supplementary file 19</xref>. The details of unique differentially expressed genes (uni-DEGs) in each fibroblast subpopulation are listed in <xref ref-type="supplementary-material" rid="supp20">Supplementary file 20</xref>. The details of the cognate ligands of <italic>Itgb1</italic> are listed in <xref ref-type="supplementary-material" rid="supp21">Supplementary file 21</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for CT values of <italic>Itgb1</italic> used for <xref ref-type="fig" rid="fig6">Figure 6H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-80479-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Source data for CT values of <italic>Itgb1</italic> used for <xref ref-type="fig" rid="fig6">Figure 6H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-80479-fig6-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Up- and downregulated genes in each fibroblast subpopulation of diabetic mice, compared with the control mice.</title><p>Lollipop plot shows the up- and downregulated genes in each fibroblast subpopulation of diabetic mice, compared with the control mice (two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>DEGs in each cardiac fibroblast subpopulation from high-fat diet (HFD)/streptozotocin (STZ)-treated or control mice with <italic>Itgb1</italic> highlighted.</title><p>Volcano plots showing the DEGs in each cardiac fibroblast subpopulation (<bold>A-J</bold> indicated Fibro_0 to Fibro_9 fibrobalst subcluster) of the HFD/STZ-treated or control mice with Itgb1 highlighted.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig6-figsupp2-v2.tif"/></fig></fig-group><p>To identify the critical signaling molecules in the <italic>Hrc<sup>hi</sup></italic> fibroblasts that mediate myocardial fibrosis during diabetics, we identified the uni-DEGs in each fibroblast subpopulation (<xref ref-type="supplementary-material" rid="supp20">Supplementary file 20</xref>) and constructed a PPI network using the upregulated genes (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). The top 15 hub genes included <italic>Itgb1</italic>, <italic>Col6a1</italic>, <italic>Col1a2</italic>, <italic>Dcn</italic>, <italic>Rpl6</italic>, <italic>Rps20</italic>, <italic>Serpinh1</italic>, <italic>Bgn</italic>, <italic>Hsp90aa1</italic>, and <italic>Col6a2</italic>, of which <italic>Col6a1</italic>, <italic>Col1a2</italic>, <italic>Col6a2</italic>, <italic>Dcn</italic>, and <italic>Bgn</italic> encode for ECM proteins (<xref ref-type="bibr" rid="bib50">Schipke et al., 2017</xref>). In addition, both <italic>Serpinh1</italic> and <italic>Hsp90aa1</italic> have been reported to participate in collagen synthesis (<xref ref-type="bibr" rid="bib10">Christiansen et al., 2010</xref>; <xref ref-type="bibr" rid="bib15">García et al., 2016</xref>). Although the role of these candidate hub genes has been well established in myocardial fibrosis, the function of <italic>Itgb1</italic> is currently unknown.</p><p>The PPI network of the upregulated uni-DEGs and immunostaining results indicate the key role of <italic>Itgb1</italic> of <italic>Hrc<sup>hi</sup></italic> fibroblasts in diabetic myocardial fibrosis (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, <italic>n</italic> = 6 mice per group; <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>, two-sided Wilcoxon rank-sum test, FDR ≤0.05, log2FC ≥0.36). <italic>Itgb1</italic> deficiency increases the risk of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (<xref ref-type="bibr" rid="bib59">Wang et al., 2020</xref>). It is therefore reasonable to surmise that the interaction between <italic>Itgb1</italic> and its cognate ligand is involved in diabetes-related myocardial fibrosis. To confirm this hypothesis, we screened all potential ligands of <italic>Itgb1</italic> (<xref ref-type="supplementary-material" rid="supp21">Supplementary file 21</xref>), and found that Lgals3bp and Fn1 were upregulated in the heart tissues of diabetic mice (<xref ref-type="fig" rid="fig6">Figure 6E - G</xref>, <italic>n</italic> = 6 mice per group).</p><p>To validate the role of <italic>Itgb1</italic> in the heart in myocardial fibrosis during diabetes, we used the adeno-associated virus 9 (AAV9) to deliver <italic>Itgb1</italic> siRNA, which preferentially targets the heart. The level of <italic>Itgb1</italic> mRNA decreased by &gt;80% in response to a single injection of <italic>Itgb1</italic> siRNA, compared with the negative control (<xref ref-type="fig" rid="fig6">Figure 6H</xref>, <italic>n</italic> = 6 mice per group, mean ± SEM, ****p &lt; 0.0001). Moreover, the knockdown of <italic>Itgb1</italic> lasted for more than 5 months after the injection of the siRNA. Next, we tested collagen synthesis and deposition in the diabetic mouse heart with <italic>Itgb1</italic> knockdown using Masson dye staining. The results showed that levels of collagen synthesis and deposition were indeed downregulated in the <italic>Itgb1</italic> knockout mice (<xref ref-type="fig" rid="fig6">Figure 6I</xref>, <italic>n</italic> = 6 mice per group). Taken together, our results show that <italic>Itgb1</italic> in <italic>Hrc<sup>hi</sup></italic> fibroblasts contributes to HFD/STZ-induced myocardial fibrosis. Further studies are warranted to establish the exact function of these ligand–receptor interactions in diabetic myocardial fibrosis.</p></sec><sec id="s2-7"><title>Validating the results of scRNA-seq data in the DB/DB diabetic mice model</title><p>To confirm if the scRNA-seq data is consistent with that of other mouse models of type 2 diabetes, we performed a data validation in the DB/DB mice. DB/DB is a spontaneous transgenic mouse model of type 2 diabetes with leptin receptor point mutation, which develops symptoms of obesity, insulin resistance, and hyperglycemia. We found that Pdgfra phosphorylation was significantly promoted in the DB/DB mice, and the phosphorylation level of Pdgfra was significantly inhibited after Ima treatment (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <italic>n</italic> = 6 mice per group). Subsequently, we examined whether Hrc-activated fibroblasts could be detected in the DB/DB mice, and we performed Hrc and Desmin co-staining experiment. Hrc was highly expressed in DB/DB diabetic mice and overlaps with the fibroblast marker Desmin, suggesting that Hrc is significantly activated in the fibroblasts of the diabetic heart. After treatment with Ima, the expression of Hrc and Desmin was significantly inhibited (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <italic>n</italic> = 6 mice per group). Finally, the qRT-PCR results of <italic>Acta2</italic> and <italic>Col3a1</italic> further confirmed that Ima treatment could significantly inhibit the accumulation of collagen fibers in the heart of the diabetic mice (<xref ref-type="fig" rid="fig7">Figure 7C, D</xref>, <italic>n</italic> = 4 mice for <italic>Acta2</italic> and <italic>n</italic> = 6 mice for <italic>Col3a1</italic>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Identification of Hrc-activated fibroblasts and Pdgfra phosphorylation in DB/DB diabetic mice.</title><p>(<bold>A</bold>) p-Pdgfra (green) and Desmin (red) labeled fibroblasts in the mice heart. (<bold>B</bold>) Hrc (green) and Desmin (red) labeled activated fibroblasts in the mice heart (<italic>n</italic> = 6 mice per group for A and B; scale bar = 50 μm). (<bold>C</bold>) <italic>Acta2</italic> mRNA expression level in the mice heart (<italic>n</italic> = 4 mice per group; mean ± standard error of mean [SEM]; *p &lt; 0.05; ***p &lt; 0.001). (<bold>D</bold>) <italic>Col3a1</italic> mRNA expression level in mice heart (<italic>n</italic> = 6 mice per group; mean ± SEM; **p &lt; 0.01; ***p &lt; 0.001).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Immunostaining results of Pdgfd and Pdgfc in the Pdgfra<sup>+</sup> fibroblasts.</title><p>Representative immunofluorescence images of Pdgfd (<bold>A</bold>) and Pdgfd (<bold>B</bold>) in the Pdgfra<sup>+</sup> cells in the heart tissues of DB/DB diabetic mice and DB/M control groups (<italic>n</italic> = 6 mice per group; scale bar = 50 µm).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig7-figsupp1-v2.tif"/></fig></fig-group><p>Next, we also examined the role of the Pdgf(s)–Pdgfra axis in the fibrogenesis of diabetic myocardium, and confirmed that Pdgf(s)–Pdgfra axis-mediated ligand–receptor interaction play a similar important role in the fibrogenic progression of the myocardium in DB/DB diabetic mice through the double immunofluorescence staining of Pdgfra with Pdgfc and Pdgfd (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, <italic>n</italic> = 6 mice per group).</p></sec><sec id="s2-8"><title>Identification of the results of scRNA-seq data in female C57 diabetic mice</title><p>To further verify the results of scRNA-seq in diabetic cardiomyopathy, we performed validation studies on female C57 mice. First, we examined whether Pdgfra is activated in the heart of diabetic mice by performing p-Pdgfra and desmin double staining, and the results showed that Pdgfra phosphorylation was significantly activated in the diabetic mice, and that phosphorylation was inhibited after Ima treatment (<xref ref-type="fig" rid="fig8">Figure 8A</xref>, <italic>n</italic> = 6 mice per group). Subsequently, we examined whether there was a subpopulation of <italic>Hrc</italic><sup>+</sup> fibroblasts in the hearts of the female diabetic mice. Hrc is highly expressed in the heart of female mice and overlaps with that of the cardiac fibroblast marker, desmin. However, Ima treatment significantly inhibited the activation of Hrc fibroblasts (<xref ref-type="fig" rid="fig8">Figure 8B</xref>, <italic>n</italic> = 6 mice per group). These results suggest that the appearance of <italic>Hrc</italic><sup>+</sup> fibroblast subsets is a common phenomenon in diabetic cardiomyopathy. Further examination of <italic>Acta2</italic> (<xref ref-type="fig" rid="fig8">Figure 8C</xref>, <italic>n</italic> = 4 mice per group) and <italic>Col3a1</italic> (<xref ref-type="fig" rid="fig8">Figure 8D</xref>, <italic>n</italic> = 4 mice per group) mRNA levels revealed that Ima treatment significantly inhibited collagen accumulation in the heart of diabetic mice.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Validation of Hrc-activated fibroblasts and Pdgfra phosphorylation in female C57 mice.</title><p>(<bold>A</bold>) p-Pdgfra (green) and Desmin (red) labeled fibroblasts in the mice heart. (<bold>B</bold>) Hrc (green) and Desmin (red) labeled activated fibroblasts in the mice heart. <italic>n</italic> = 6 mice per group for A and B; scale bar = 50 μm. (<bold>C</bold>) <italic>Acta2</italic> mRNA expression level in the mice heart (<italic>n</italic> = 4 mice per group; mean ± standard error of mean [SEM], *p &lt; 0.05; ***p &lt; 0.001). (<bold>D</bold>) <italic>Col3a1</italic> mRNA expression level in mice heart (<italic>n</italic> = 4 mice per group; mean ± SEM; **p &lt; 0.01; ***p &lt; 0.001).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Immunofluorescence results of Pdgfd and Pdgfc in the Pdgfra<sup>+</sup> fibroblasts.</title><p>Representative immunofluorescence images for Pdgfd (<bold>A</bold>) and Pdgfd (<bold>B</bold>) in the Pdgfra<sup>+</sup> cells in the heart tissues of female C57 diabetic mice and control groups (<italic>n</italic> = 6 mice per group; scale bar = 50 µm).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-fig8-figsupp1-v2.tif"/></fig></fig-group><p>Finally, we further examined whether the Pdgf(s)–Pdgfra interactions are involved in the pathogenesis of diabetic myocardial fibrosis. The results suggest that ligand–receptor interactions between macrophages, endothelial cells, and fibroblasts play an important role in promoting myocardial fibrosis (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>, <italic>n</italic> = 6 mice per group). This theory has been validated in both male C57 mice and DB/DB diabetes model and appears to be a common mechanism that promotes cardiac fibrosis in diabetes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>scRNA-seq allows for the in-depth analysis of individual cells in heterogenous populations (<xref ref-type="bibr" rid="bib6">Butler et al., 2018</xref>) in healthy and diseased tissues (<xref ref-type="bibr" rid="bib1">Ackers-Johnson et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Mathys et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Peng et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Kalucka et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Litviňuková et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Li et al., 2021</xref>). However, the effect of diabetes on cardiac cell function and cardiac cell heterogeneity at single-cell level has not been previously reported. In this study, we mapped out the transcriptional alterations associated with HFD/STZ-induced diabetes in different cardiac cell populations, and identified the key ligand–receptor pair drivers of myocardial fibrosis in the fibroblasts of the diabetic heart. Specifically, the emergence of <italic>Hrc<sup>hi</sup></italic> fibroblast subpopulations in response to diabetic progression, presumably to remodel the extracellular environment through multiple ligand–receptor interactions. In addition, the appearance of the <italic>Postn</italic><sup>+</sup> fibroblast subpopulation was also identified in this study. Interestingly, a subset of <italic>Postn</italic><sup>+</sup> fibroblasts was found in both human dilated cardiomyopathy and mouse cardiac hypertrophy models (<xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>), and our scRNA-seq results also identified <italic>Postn</italic><sup>+</sup> fibroblasts. These results suggest that <italic>Postn</italic><sup>+</sup> fibroblasts may play a similar important role in the various pathology of cardiac fibrosis.</p><p>The heart of a mammal is a complex organ composed of a variety of cell types (<xref ref-type="bibr" rid="bib5">Banerjee et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Litviňuková et al., 2020</xref>). Cardiac fibroblasts synthesize extracellular matrix proteins and their excessive activation in response to stress induced cardiac fibrosis (<xref ref-type="bibr" rid="bib58">Travers et al., 2016</xref>). GO enrichment analysis of all upregulated genes in the cardiac cell populations from the diabetic mice confirmed the association of fibroblasts and extracellular matrix remodeling with myocardial fibrosis, which is consistent with the results of previous studies (<xref ref-type="bibr" rid="bib23">Jia et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Ivey et al., 2019</xref>; <xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>; <xref ref-type="bibr" rid="bib14">Frangogiannis, 2021</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>). The survival and proper functioning of metazoans depends on communication between multiple cell populations and tissues via secretary ligands and membrane receptors (<xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>). Therefore, we screened for receptor genes that were highly expressed in the cardiac fibroblasts of diabetic mice and their cognate ligands that were upregulated in other cardiac cell populations to identify the dysregulated ligand–fibroblast receptor interactions. Protein–protein interaction network analysis indicated that the receptors, <italic>Pdgfra</italic> and <italic>Egfr</italic>, which are highly expressed in the fibroblasts, play a central role in myocardial fibrosis in diabetes. Pdgfra is a surface receptor tyrosine kinase that is activated upon binding to its corresponding ligand Pdgf(s), and regulates cell division and proliferation (<xref ref-type="bibr" rid="bib48">Rudat et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Gouveia et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Soliman et al., 2020</xref>). Egfr on the other hand is a member of the ErbB family of receptor tyrosine kinases and plays an important role in wound healing and cardiac hypertrophy (<xref ref-type="bibr" rid="bib43">Peng et al., 2016</xref>). The upregulation of the Pdgfra ligands, Pdgfb and Pdgfd in endothelial cells and Pdgfc in macrophages, and that of the Egfr ligand, Efemp1 in epicardial cells of the HFD/STZ-treated mice indicate that the cardiac microenvironment had changed, resulting in extracellular matrix remodeling and cardiac fibrosis. This is of particular interest given the pathological role of these cell populations and ligand–receptor pairs in cardiovascular diseases (<xref ref-type="bibr" rid="bib46">Rottlaender et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Shinagawa and Frantz, 2015</xref>; <xref ref-type="bibr" rid="bib12">Farbehi et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Marín-Juez et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Peet et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Baguma-Nibasheka et al., 2021</xref>). Ligand–receptor pair analysis also revealed the synergistic role of endothelial cells, macrophages, and epicardial cells with fibroblasts in diabetic myocardial fibrosis. Further analysis of the interactions between these cell populations will help us understand the pathogenesis of diabetes-induced fibrosis.</p><p>Terminally differentiated cells are generally considered to have limited plasticity. Cellular plasticity in adults is mostly reported during the terminal differentiation stage of many progenitor cells (<xref ref-type="bibr" rid="bib8">Chang-Panesso and Humphreys, 2017</xref>). However, these cellular transitions may also be present in cardiac fibroblasts. Unbiased single-cell clustering can redefine cell type based on the global transcriptome patterns (<xref ref-type="bibr" rid="bib47">Rozenblatt-Rosen et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Ackers-Johnson et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>). Such analyses have already been applied to other organs (<xref ref-type="bibr" rid="bib36">Macosko et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Stubbington et al., 2017</xref>) and even to whole multicellular organisms (<xref ref-type="bibr" rid="bib7">Cao et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Karaiskos et al., 2017</xref>). These experiments have identified new cells as well as previously defined cells with catalogued marker genes, demonstrating that this approach can be used to redefine cardiac cell types. One of the most important results of the mouse cardiac fibroblasts analysis was the identification of two different phenotypic <italic>Hrc<sup>hi</sup></italic> and <italic>Postn<sup>hi</sup></italic> fibroblast subpopulations associated with extracellular matrix remodeling. The Postn<sup>hi</sup> fibroblasts participate in fibrogenic progression, which is consistent with another subpopulation of fibroblasts identified in an animal model of angiotensin-induced myocardial hypertrophy (<xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Koenig et al., 2022</xref>), suggesting that these fibroblasts may contribute to both myocardial hypertrophy and cardiac fibrosis. <italic>Hrc<sup>hi</sup></italic> fibroblasts express fibrogenic marker genes, such as <italic>Nppa</italic>, <italic>Ttn</italic>, and <italic>Clu</italic>, which indicates a key pro-fibrotic function. <italic>Hrc</italic> knockout or AAV-mediated knockdown results in pulmonary edema, severe cardiac hypertrophy, fibrosis, heart failure, and decreased survival after transverse aortic constriction in mice (<xref ref-type="bibr" rid="bib40">Park et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Park et al., 2013</xref>). Combined with our single-cell sequencing results, we can surmise that <italic>Hrc</italic> is a potential target for the inhibition of myocardial fibrosis during diabetes.</p><p>Strikingly, GSVA and GO analyses of each fibroblast subpopulation indicated that the <italic>Hrc<sup>hi</sup></italic> fibroblasts were the most profibrogenic under diabetic conditions. This finding suggests that the <italic>Hrc<sup>hi</sup></italic> fibroblasts may be key cellular drivers of myocardial fibrosis in diabetes. We speculated that intercellular communication between <italic>Hrc<sup>hi</sup></italic> fibroblasts and other cardiac cells is a constitutive process activated in diabetes. Intercellular and protein-protein interaction networks within the <italic>Hrc<sup>hi</sup></italic> fibroblasts reveal the key role of the receptor, <italic>Itgb1</italic>, in diabetic myocardial fibrosis. The potential ligands of Itgb1, Lgals3bp, and Fn1, are upregulated in the heart tissues of diabetic mice. Perhaps, the gain-of-function of the Lgals3bp–Itgb1 and Fn1–Itgb1 pairs may explain the role of <italic>Hrc<sup>hi</sup></italic> fibroblasts in diabetic myocardial fibrosis.</p><p>In summary, we mapped the transcriptional alterations associated with HFD/STZ-induced diabetes in different cardiac subpopulations, and identified key ligand–receptor pair drivers of myocardial fibrosis in the diabetic heart, specifically the Pdgf(s)–Pdgfra and Efemp1–Egfr interactions, which are mediated by fibroblasts with macrophages, endothelial cells, and epicardial cells. Crucially, <italic>Hrc<sup>hi</sup></italic> fibroblasts were identified as the key profibrogenic subpopulation that may contribute to cardiac fibrosis by remodeling the extracellular environment through drivers of intercellular communication mediated by Itgb1. Therefore, we speculate that the specific targeting of <italic>Hrc<sup>hi</sup></italic> fibroblasts will be a promising target for the treatment of myocardial fibrosis. Our future research direction will involve the combination of fibroblast-specific <italic>Hrc</italic> knockout mice and the analysis of cardiac cellular networks to confirm the role of <italic>Hrc</italic> in regulating diabetic myocardial fibrosis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals and treatments</title><p>Male and female C57BL/6J mice weighing 18–22 g that were 6 weeks old were purchased from the Center for Laboratory Animals, Soochow University. After 1 week of acclimatization, a diabetic mouse model was constructed as previously described with some modifications (<xref ref-type="bibr" rid="bib35">Lu et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Li et al., 2017</xref>). The mice in the normal group were fed on a normal diet, while all mice in the other groups were fed with HFD (60% fat, 20% protein, and 20% carbohydrate) during the animal experiments. After 6 weeks of HFD feeding, the mice in the diabetic control model and imatinib group were fasted for 12 hr every night and injected with STZ (35 mg/kg, dissolved in 0.1 mM cold citrate buffer, pH 4.4) for 3 days to induce diabetes. Meanwhile, the control group was injected with a citrate buffer. After a week of STZ injection, the 12 hr fasting glucose level of all mice was measured. Mice with fasting blood glucose levels of ≥11.1 mmol/l (<xref ref-type="bibr" rid="bib62">Yu et al., 2014</xref>) were considered to be type 2 diabetes mice. Then, imatinib (40 mg/kg) was administered daily through intraperitoneal injection during the procedure. After 21 weeks of the injection of STZ, the mice were anesthetized using an intraperitoneal injection of pentobarbital sodium. The hearts were dissected and stored at −80℃ for further analysis. During the experiment, the mice were kept on their respective diets and their body weight was measured weekly. All procedures were performed with minimal damage to the mice. DB/DB and DB/M transgenic mice that were 8 weeks old were purchased from the Center for Laboratory Animals, Soochow University. For the DB/M normal control group, the mice were fed on a normal diet, while the diabetic DB/DB mice were divided into two groups, one was diabetic control group and the other was Ima treatment group. After 8 weeks of injection of Ima, all mice were euthanized and the hearts were dissected for further analysis.</p></sec><sec id="s4-2"><title>Echocardiographic evaluation</title><p>We performed echocardiographic measurements before and after the experimental intervention. A Vevo 2100TM High Resolution Imaging System (Visual Sonics) was used for M-mode echocardiography. According to a previous study, an evaluation of the following structural variables was conducted: left ventricular internal dimension in diastole (LVIDD), left ventricular internal dimension in systole (LVIDS), interventricular septal thickness in diastole (IVSd) and in systole (IVSs), and LV posterior wall thickness in diastole (LVPWd) and systole (LVPWs). Ejection fraction (EF), fractional shortening (FS), and E/A ratio were used to evaluate left ventricular (LV) function. We calculated the LV mass using the formula [(LVIDd + LVPWd + IVSd)3 − (LVIDd)3 × 1.04 × 0.8 + 0.6].</p></sec><sec id="s4-3"><title>Immunofluorescence</title><p>After fixing in 4% paraformaldehyde(PFA) and dehydrating with 20% sucrose, the hearts were embedded in the optimal cutting temperature compound and stored at −80°C. They were then sectioned using a Leica CM1950 system into 10-µm-thick horizontal slices. The sections were incubated with the primary antibody (anti-CD68 (Abcam, ab955), anti-CD31 (Abcam, ab28364), anti-CD31 (BD, 553700), anti-Pdgfb (CST, 3169T), anti-Pdgfc (Abcam, ab200401), anti-Pdgfd (Abcam, ab234666), anti-Pdgfra (R&amp;D, AF1062-SP), anti-phospho-Pdgfra (Tyr754) (Thermo Fisher, 441008G), anti-Vim (R&amp;D, BAM2105), anti-Hrc (Proteintech, 18142-1-AP), anti-Postn (R&amp;D, AF2955-SP), anti-Itgb1 (Invitrogen, 14-0299-82), anti-FN1 (Abcam, ab2413), and anti-Lgals3bp (Abcam, ab236509)) or an IgG control for the immunofluorescence staining. The fluorescent secondary antibodies (goat anti mouse IgM Alexa Fluor 647, abcam, ab150123, or donkey anti rabbit IgG Alexa Fluor 568, abcam, ab175470) and DAPI (SouthernBiotech, 0100-01) were used to visualize the specific proteins. Wheat Germ Agglutinin (WGA) kit was obtained from (Thermo Fisher, W11261).</p></sec><sec id="s4-4"><title>Real-time quantitative polymerase chain reaction</title><p>Total RNA from the mouse hearts was extracted using QIAGEN’s miRNeasy Mini kit (217004; Qiagen, Germany). The reverse transcription step was performed using Takara’s PrimeScript RT Master Mix (RR036A; Takara, Japan). A brilliant SYBR green PCR master mix (4913914, Roche, Switzerland) was used to perform qPCR on the cDNA templates in a LightCycler 480 system (Roche, Switzerland). The target mRNA expression levels were normalized to that of <italic>Gapdh</italic> and the relative fold change was calculated using the 2<sup>−ΔΔCT</sup> method. The qPCR primers for <italic>Col1a1</italic> (forward 5′- <named-content content-type="sequence">AACTCCCTCCACCCCAATCT</named-content>, reverse 5′-<named-content content-type="sequence">CCATGGAGATGCCAGATGGTT</named-content>), <italic>Col3a1</italic> (forward 5′-<named-content content-type="sequence">ACGTAAGCACTGGTGGACAG</named-content>, reverse 5′-<named-content content-type="sequence">GGAGGGCCATAGCTGAACTG</named-content>), <italic>Itgb1</italic> (forward 5′-<named-content content-type="sequence">ATGCCAAATCTTGCGGAG AAT</named-content>, reverse 5′-<named-content content-type="sequence">TTTGCTGCGATTGGTGACATT</named-content>), and <italic>Gapdh</italic> (forward 5′<named-content content-type="sequence">-GGTCATCCATGACAACTT</named-content>, reverse 5′<named-content content-type="sequence">-GGGGCCATCCACAGTCTT</named-content>) were designed and synthesized by Invitrogen (Shanghai, China).</p></sec><sec id="s4-5"><title>siRNA-mediated knockdown of <italic>Itgb1</italic> in the mice heart</title><p>The siRNAs targeting <italic>Itgb1</italic> were used, as previously reported (<xref ref-type="bibr" rid="bib56">Speicher et al., 2014</xref>). Sense 5′-AGAuGAGGuucAAuuuGAAdTsdT, antisense 5′-UUcAAAUUGAACCUcAUCUdTsdT. Negative control: sense 5′-cuuAcGcuGAGuAcuucGAdTsdT, antisense 5′-UCGAAGuACUcAGCGuAAGdTsdT. These targeted siRNA sequences were subcloned into an AAV9 plasmid vector and packaged into a AAV virus particle in vitro, and the titers of the AAV viruses were ensured to exceed 1 × 10<sup>12</sup> vg/ml. Diabetic C57BL/6 male mice received the negative control or <italic>Itgb1</italic> siRNA mediated by AAV (0.5 mg/kg) via tail vein injection at a volume of 5 ml/kg body weight on days 1 and 5 after the first STZ injection. At day 10 and month 5, the knockdown efficiency of Itgb1 was determined in the mice heart.</p></sec><sec id="s4-6"><title>Isolation of the nuclei from heart tissue</title><p>Isolation of nuclei from heart tissue were analyzed, as previously described (<xref ref-type="bibr" rid="bib39">McLellan et al., 2020</xref>). In Brief, mouse heart tissues were homogenized using a Wheaton Dounce Tissue Grinder. Then, 3 ml of the homogenization buffer was added and incubated the homogenized tissue on ice for 5 min. Then, the homogenized tissue was filtered through a 40 mm cell strainer, mixed with an equal volume of working solution and loaded into the top of an OptiPrep density gradient on top of 5 ml of 35% OptiPrep solution. The nuclei were separated through ultracentrifugation using an SW32 rotor (20 min, 9000 rpm). Thereafter, 3 ml of the nuclei were collected at the 29%/35% interphase and washed with 30 ml of phosphate-buffered saline (PBS) containing 0.04% bovine serum albumin (BSA). The nuclei were centrifuged at 300 × <italic>g</italic> for 3 min and washed with 20 ml of PBS containing 0.04% BSA. Then, the nuclei were centrifuged at 300 × <italic>g</italic> for 3 min and resuspended in 500 ml of PBS containing 0.04% BSA. All procedures were conducted on ice or at 4°C.</p></sec><sec id="s4-7"><title>Single-nucleus transcriptomic library preparation</title><p>Single-nucleus transcriptomic library preparation were performed as previously described (<xref ref-type="bibr" rid="bib32">Li et al., 2021</xref>). Briefly, single nucleus was resuspended in PBS containing 0.04% BSA and added to each channel. The captured nucleus was lysed, and the RNA released was barcoded through reverse transcription in individual GEMs. Barcoded cDNA was amplified, and the quality was controlled using an Agilent 4200 TapeStation System. scRNA-seq libraries were prepared using Single Cell 3′ Library and Gel Bead Kit V3 following the manufacturer’s introduction. Sequencing was performed on an Illumina Novaseq 6000 sequencer using a pair-end 150 bp (PE150) reading strategy (performed by Gene Denovo Biotechnology Co, Guangzhou, China).</p></sec><sec id="s4-8"><title>Clustering analysis</title><p>Alignment, filtering, barcode counting, and UMI counting were performed with Cell Ranger to generate a feature-barcode matrix and their global gene expression. Dimensionality reduction, visualization, and analysis of the scRNA-sequencing data were performed with the R package Seurat (version 3.1.2). As a further quality-control measure, nuclei that met any of the following criteria were filtered out: &lt;500 or&gt;4000 unique genes expressed, &gt;8000 UMIs, or &gt;10% of reads mapped to the mitochondria. After removing unwanted nuclei from the dataset, 2000 highly variable genes were used for the downstream clustering analysis. Principal component analysis (PCA) was performed, and the number of the significant principal components was calculated using the built-in ‘ElbowPlot’ function.</p></sec><sec id="s4-9"><title>Differentially expressed genes analysis</title><p>The expression level of each gene in the target cluster was compared with other cells using the Wilcoxon rank-sum test. The significantly upregulated genes were identified using the following criteria: (1) at least 1.28-fold overexpression in the target cluster, (2) expression in more than 25% of the cells belonging to the target cluster, and (3) FDR is less than 0.05.</p></sec><sec id="s4-10"><title>Gene set variation analysis</title><p>To identify cellular processes and pathways that were enriched in the different clusters, GSVA was performed using the GSVA R package (<xref ref-type="bibr" rid="bib20">Hänzelmann et al., 2013</xref>) version 1.26, based on the cluster-averaged log-transformed expression matrix.</p></sec><sec id="s4-11"><title>GO and KEGG pathway enrichment analysis of the differentially expressed genes</title><p>GO and KEGG pathway enrichment analysis identified significantly enriched cellular processes and pathways in differentially expressed genes comparing with the whole genome background. The calculated p-value was gone through FDR correction, taking FDR ≤0.05 as a threshold. GO term and KEGG pathways that met this condition were defined as the significantly enriched pathways in differentially expressed genes.</p></sec><sec id="s4-12"><title>Regulon analysis</title><p>Regulon analysis was performed on the SCENIC R package to carry out transcription factor network inference (<xref ref-type="bibr" rid="bib2">Aibar et al., 2017</xref>). In brief, gene expression matrix was used as the input, and the pipeline was implanted in three steps. First, the gene co-expression network was identified via GENIE3 (<xref ref-type="bibr" rid="bib21">Huynh-Thu et al., 2010</xref>). Second, we pruned each module based on a regulatory motif near a transcription start site via RcisTarget. Third, we scored the activity of each regulon for each single cell via theArea Under Curve (AUC) scores using AUCell R package.</p></sec><sec id="s4-13"><title>Statistical analyses</title><p>The statistical analysis of the results was performed using GraphPad Prism 9.0 software. Unpaired <italic>t</italic>-test or one-way analysis of variance was used to calculate the differences in mean values. A p-value ≤0.05 was considered statistically significant. Other statistical analyses not described above were performed using the ggpubr package in R software (<ext-link ext-link-type="uri" xlink:href="https://github.com/kassambara/ggpubr">https://github.com/kassambara/ggpubr</ext-link> copy archived at <xref ref-type="bibr" rid="bib33">Li, 2023</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con9"><p>Conceptualization</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Provide guidance during manuscript writing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Funding acquisition, Writing – original draft, Writing – review and editing, Investigation, Formal analysis</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was approved by the Ethics Committee of Soochow University and Suzhou Science &amp; Technology Town Hospital, Gusu School, Nanjing Medical University. Reference number: 2022-B23. All mice were treated in accordance with the National Institutes of Health's Guidelines for the Care and Use of Experimental Animals (NIH publications no. 80-23, revised 1996).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The 25 transcriptionally distinct pre-clusters with highly consistent expression patterns across individual mice hearts.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp1-v2.xls"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Genes with significant transcriptomic changes in the cardiac populations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp2-v2.xls"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>The top 10 upregulated genes in the cardiac populations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp3-v2.xls"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Unique differentially expressed genes (uni-DEGs) in the cardiac populations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp4-v2.xls"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Significantly differentially expressed genes in specific cell populations relative to others in mice hearts.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp5-v2.xls"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Cell type-specific receptors in the cardiac populations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp6-v2.xls"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Cell type-specific ligands in the cardiac populations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp7-v2.xls"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Relative expression of a selection of essential growth factors across the major cardiac cell types.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp8-v2.xls"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>The number of ligand–receptor pairs among the cardiac cell populations in the healthy mice.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp9-v2.xls"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>Ligand–receptor pairs among the cardiac cell populations in the healthy mice.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp10-v2.xls"/></supplementary-material><supplementary-material id="supp11"><label>Supplementary file 11.</label><caption><title>Significantly differentially expressed ligands in each cell population.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp11-v2.xls"/></supplementary-material><supplementary-material id="supp12"><label>Supplementary file 12.</label><caption><title>Significantly differentially expressed receptors in each cell population.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp12-v2.xls"/></supplementary-material><supplementary-material id="supp13"><label>Supplementary file 13.</label><caption><title>The cognate ligands of Egfr.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp13-v2.xls"/></supplementary-material><supplementary-material id="supp14"><label>Supplementary file 14.</label><caption><title>The cognate ligands of Pdgfra.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp14-v2.xls"/></supplementary-material><supplementary-material id="supp15"><label>Supplementary file 15.</label><caption><title>Ten transcriptionally distinct fibroblast subpopulations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp15-v2.xls"/></supplementary-material><supplementary-material id="supp16"><label>Supplementary file 16.</label><caption><title>Distinct signatures of each fibroblast subpopulations in mice hearts.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp16-v2.xls"/></supplementary-material><supplementary-material id="supp17"><label>Supplementary file 17.</label><caption><title>The transcription factor gene-regulatory networks in the distinct subpopulations.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp17-v2.xls"/></supplementary-material><supplementary-material id="supp18"><label>Supplementary file 18.</label><caption><title>Gene expression of the transcription factors shown in <xref ref-type="fig" rid="fig5">Figure 5A, B</xref>.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp18-v2.xls"/></supplementary-material><supplementary-material id="supp19"><label>Supplementary file 19.</label><caption><title>Genes with significant transcriptomic changes in each fibroblast subpopulation.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp19-v2.xls"/></supplementary-material><supplementary-material id="supp20"><label>Supplementary file 20.</label><caption><title>Unique differentially expressed genes (uni-DEGs) in each fibroblast subpopulation.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp20-v2.xls"/></supplementary-material><supplementary-material id="supp21"><label>Supplementary file 21.</label><caption><title>The cognate ligands of Itgb1.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-80479-supp21-v2.xls"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-80479-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All sequencing data that support this study is available from the Genome Sequence Archive in BIG Data Center (<ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/">http://bigd.big.ac.cn/</ext-link>) with the accession code CRA007245. The ligand and receptor pairing dataset was obtained from Fantom5 (<ext-link ext-link-type="uri" xlink:href="https://fantom.gsc.riken.jp/5/suppl/Ramilowski_et_al_2015/">https://fantom.gsc.riken.jp/5/suppl/Ramilowski_et_al_2015/</ext-link>), as described in <xref ref-type="bibr" rid="bib45">Ramilowski et al., 2015</xref>. Source data files are provided to support CT values of Col1a1 and Col3a1 used for Figure 3G,H. Source data files are provided to support CT values of Itgb1 used for Figure 6H. Source data files are provided to support Table 1 in Figure 3—Figure supplement 5.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lou</surname><given-names>X</given-names></name><name><surname>Zha</surname><given-names>Y</given-names></name><name><surname>Zha</surname><given-names>J</given-names></name><name><surname>Hong</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Qiao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Single-Cell RNA-seq of Heart Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Mice</data-title><source>CNCB Genome Sequence Archive</source><pub-id pub-id-type="accession" xlink:href="https://ngdc.cncb.ac.cn/search/?dbId=gsa&amp;q=CRA007245">CRA007245</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Ramilowski</surname><given-names>JA</given-names></name><name><surname>Goldberg</surname><given-names>T</given-names></name><name><surname>Harshbarger</surname><given-names>J</given-names></name><name><surname>Kloppman</surname><given-names>E</given-names></name><name><surname>Lizio</surname><given-names>M</given-names></name><name><surname>Satagopam</surname><given-names>VP</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name><name><surname>Forrest</surname><given-names>ARR</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>A draft network of ligand-receptor-mediated multicellular signalling in human</data-title><source>Fantom5</source><pub-id pub-id-type="accession" xlink:href="https://fantom.gsc.riken.jp/5/suppl/Ramilowski_et_al_2015/">fantom</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Guangzhou Gene Denovo Biotechnology Co (Guangzhou, China) for the technical support for single-cell RNA sequencing of normal and T2DM mouse heart, and thank Professor Huiling Zhang’s team of the College of Pharmaceutical Science in Soochow University for their friendly help with the experiments on diabetic myocardial fibrosis in mice. Thanks to the public research platform of Soochow University for their technical support of this experiment. We would also like to thank the native English speaker from CureEdit who improved the grammar and readability of our manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackers-Johnson</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>WLW</given-names></name><name><surname>Foo</surname><given-names>RS-Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Following hearts, one cell at a time: recent applications of single-cell RNA sequencing to the understanding of heart disease</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4434</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06894-8</pub-id><pub-id pub-id-type="pmid">30375391</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>González-Blas</surname><given-names>CB</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Rambow</surname><given-names>F</given-names></name><name><surname>Marine</surname><given-names>J-C</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><name><surname>van den Oord</surname><given-names>J</given-names></name><name><surname>Atak</surname><given-names>ZK</given-names></name><name><surname>Wouters</surname><given-names>J</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SCENIC: single-cell regulatory network inference and clustering</article-title><source>Nature Methods</source><volume>14</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelial cells and the IGF system</article-title><source>Journal of Molecular Endocrinology</source><volume>54</volume><fpage>R1</fpage><lpage>R13</lpage><pub-id pub-id-type="doi">10.1530/JME-14-0215</pub-id><pub-id pub-id-type="pmid">25351818</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baguma-Nibasheka</surname><given-names>M</given-names></name><name><surname>Feridooni</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Pasumarthi</surname><given-names>KBS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Regulation of transplanted cell homing by FGF1 and PDGFB after doxorubicin myocardial injury</article-title><source>Cells</source><volume>10</volume><elocation-id>2998</elocation-id><pub-id pub-id-type="doi">10.3390/cells10112998</pub-id><pub-id pub-id-type="pmid">34831221</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>I</given-names></name><name><surname>Fuseler</surname><given-names>JW</given-names></name><name><surname>Price</surname><given-names>RL</given-names></name><name><surname>Borg</surname><given-names>TK</given-names></name><name><surname>Baudino</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>293</volume><fpage>H1883</fpage><lpage>H1891</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00514.2007</pub-id><pub-id pub-id-type="pmid">17604329</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Ramani</surname><given-names>V</given-names></name><name><surname>Cusanovich</surname><given-names>DA</given-names></name><name><surname>Huynh</surname><given-names>C</given-names></name><name><surname>Daza</surname><given-names>R</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Furlan</surname><given-names>SN</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Adey</surname><given-names>A</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive single-cell transcriptional profiling of a multicellular organism</article-title><source>Science</source><volume>357</volume><fpage>661</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1126/science.aam8940</pub-id><pub-id pub-id-type="pmid">28818938</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang-Panesso</surname><given-names>M</given-names></name><name><surname>Humphreys</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cellular plasticity in kidney injury and repair</article-title><source>Nature Reviews. Nephrology</source><volume>13</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2016.169</pub-id><pub-id pub-id-type="pmid">27890924</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Chou</surname><given-names>CL</given-names></name><name><surname>Nair</surname><given-names>AV</given-names></name><name><surname>Battistone</surname><given-names>MA</given-names></name><name><surname>Păunescu</surname><given-names>TG</given-names></name><name><surname>Merkulova</surname><given-names>M</given-names></name><name><surname>Breton</surname><given-names>S</given-names></name><name><surname>Verlander</surname><given-names>JW</given-names></name><name><surname>Wall</surname><given-names>SM</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Burg</surname><given-names>MB</given-names></name><name><surname>Knepper</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptomes of major renal collecting duct cell types in mouse identified by single-cell RNA-seq</article-title><source>PNAS</source><volume>114</volume><fpage>E9989</fpage><lpage>E9998</lpage><pub-id pub-id-type="doi">10.1073/pnas.1710964114</pub-id><pub-id pub-id-type="pmid">29089413</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>HE</given-names></name><name><surname>Schwarze</surname><given-names>U</given-names></name><name><surname>Pyott</surname><given-names>SM</given-names></name><name><surname>AlSwaid</surname><given-names>A</given-names></name><name><surname>Al Balwi</surname><given-names>M</given-names></name><name><surname>Alrasheed</surname><given-names>S</given-names></name><name><surname>Pepin</surname><given-names>MG</given-names></name><name><surname>Weis</surname><given-names>MA</given-names></name><name><surname>Eyre</surname><given-names>DR</given-names></name><name><surname>Byers</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta</article-title><source>American Journal of Human Genetics</source><volume>86</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2010.01.034</pub-id><pub-id pub-id-type="pmid">20188343</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>AP</given-names></name><name><surname>Campos</surname><given-names>J</given-names></name><name><surname>Jansen</surname><given-names>K</given-names></name><name><surname>Turner</surname><given-names>JD</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Attar</surname><given-names>M</given-names></name><name><surname>Savary</surname><given-names>L</given-names></name><name><surname>Wehmeyer</surname><given-names>C</given-names></name><name><surname>Naylor</surname><given-names>AJ</given-names></name><name><surname>Kemble</surname><given-names>S</given-names></name><name><surname>Begum</surname><given-names>J</given-names></name><name><surname>Dürholz</surname><given-names>K</given-names></name><name><surname>Perlman</surname><given-names>H</given-names></name><name><surname>Barone</surname><given-names>F</given-names></name><name><surname>McGettrick</surname><given-names>HM</given-names></name><name><surname>Fearon</surname><given-names>DT</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name><name><surname>Coles</surname><given-names>M</given-names></name><name><surname>Sansom</surname><given-names>SN</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name><name><surname>Buckley</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct fibroblast subsets drive inflammation and damage in arthritis</article-title><source>Nature</source><volume>570</volume><fpage>246</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1263-7</pub-id><pub-id pub-id-type="pmid">31142839</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farbehi</surname><given-names>N</given-names></name><name><surname>Patrick</surname><given-names>R</given-names></name><name><surname>Dorison</surname><given-names>A</given-names></name><name><surname>Xaymardan</surname><given-names>M</given-names></name><name><surname>Janbandhu</surname><given-names>V</given-names></name><name><surname>Wystub-Lis</surname><given-names>K</given-names></name><name><surname>Ho</surname><given-names>JW</given-names></name><name><surname>Nordon</surname><given-names>RE</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury</article-title><source>eLife</source><volume>8</volume><elocation-id>e43882</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43882</pub-id><pub-id pub-id-type="pmid">30912746</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forte</surname><given-names>E</given-names></name><name><surname>Skelly</surname><given-names>DA</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Daigle</surname><given-names>S</given-names></name><name><surname>Morelli</surname><given-names>KA</given-names></name><name><surname>Hon</surname><given-names>O</given-names></name><name><surname>Philip</surname><given-names>VM</given-names></name><name><surname>Costa</surname><given-names>MW</given-names></name><name><surname>Rosenthal</surname><given-names>NA</given-names></name><name><surname>Furtado</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dynamic interstitial cell response during myocardial infarction predicts resilience to rupture in genetically diverse mice</article-title><source>Cell Reports</source><volume>30</volume><fpage>3149</fpage><lpage>3163</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.008</pub-id><pub-id pub-id-type="pmid">32130914</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cardiac fibrosis</article-title><source>Cardiovascular Research</source><volume>117</volume><fpage>1450</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvaa324</pub-id><pub-id pub-id-type="pmid">33135058</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García</surname><given-names>R</given-names></name><name><surname>Merino</surname><given-names>D</given-names></name><name><surname>Gómez</surname><given-names>JM</given-names></name><name><surname>Nistal</surname><given-names>JF</given-names></name><name><surname>Hurlé</surname><given-names>MA</given-names></name><name><surname>Cortajarena</surname><given-names>AL</given-names></name><name><surname>Villar</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Extracellular heat shock protein 90 binding to TGFβ receptor I participates in TGFβ-mediated collagen production in myocardial fibroblasts</article-title><source>Cellular Signalling</source><volume>28</volume><fpage>1563</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2016.07.003</pub-id><pub-id pub-id-type="pmid">27418101</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladka</surname><given-names>MM</given-names></name><name><surname>Molenaar</surname><given-names>B</given-names></name><name><surname>de Ruiter</surname><given-names>H</given-names></name><name><surname>van der Elst</surname><given-names>S</given-names></name><name><surname>Tsui</surname><given-names>H</given-names></name><name><surname>Versteeg</surname><given-names>D</given-names></name><name><surname>Lacraz</surname><given-names>GPA</given-names></name><name><surname>Huibers</surname><given-names>MMH</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>van Rooij</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-Cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation</article-title><source>Circulation</source><volume>138</volume><fpage>166</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.030742</pub-id><pub-id pub-id-type="pmid">29386203</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glebova</surname><given-names>NO</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Heterogeneous requirement of NGF for sympathetic target innervation in vivo</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>743</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4523-03.2004</pub-id><pub-id pub-id-type="pmid">14736860</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouveia</surname><given-names>L</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name><name><surname>Andrae</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PDGF-A signaling is required for secondary alveolar septation and controls epithelial proliferation in the developing lung</article-title><source>Development</source><volume>145</volume><elocation-id>dev161976</elocation-id><pub-id pub-id-type="doi">10.1242/dev.161976</pub-id><pub-id pub-id-type="pmid">29636361</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grindberg</surname><given-names>RV</given-names></name><name><surname>Yee-Greenbaum</surname><given-names>JL</given-names></name><name><surname>McConnell</surname><given-names>MJ</given-names></name><name><surname>Novotny</surname><given-names>M</given-names></name><name><surname>O’Shaughnessy</surname><given-names>AL</given-names></name><name><surname>Lambert</surname><given-names>GM</given-names></name><name><surname>Araúzo-Bravo</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Fishman</surname><given-names>M</given-names></name><name><surname>Robbins</surname><given-names>GE</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Venepally</surname><given-names>P</given-names></name><name><surname>Badger</surname><given-names>JH</given-names></name><name><surname>Galbraith</surname><given-names>DW</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Lasken</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA-sequencing from single nuclei</article-title><source>PNAS</source><volume>110</volume><fpage>19802</fpage><lpage>19807</lpage><pub-id pub-id-type="doi">10.1073/pnas.1319700110</pub-id><pub-id pub-id-type="pmid">24248345</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hänzelmann</surname><given-names>S</given-names></name><name><surname>Castelo</surname><given-names>R</given-names></name><name><surname>Guinney</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>GSVA: gene set variation analysis for microarray and RNA-Seq data</article-title><source>BMC Bioinformatics</source><volume>14</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id><pub-id pub-id-type="pmid">23323831</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Irrthum</surname><given-names>A</given-names></name><name><surname>Wehenkel</surname><given-names>L</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inferring regulatory networks from expression data using tree-based methods</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e12776</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0012776</pub-id><pub-id pub-id-type="pmid">20927193</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivey</surname><given-names>MJ</given-names></name><name><surname>Kuwabara</surname><given-names>JT</given-names></name><name><surname>Riggsbee</surname><given-names>KL</given-names></name><name><surname>Tallquist</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>317</volume><fpage>H330</fpage><lpage>H344</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00054.2019</pub-id><pub-id pub-id-type="pmid">31125253</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>G</given-names></name><name><surname>Whaley-Connell</surname><given-names>A</given-names></name><name><surname>Sowers</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease</article-title><source>Diabetologia</source><volume>61</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1007/s00125-017-4390-4</pub-id><pub-id pub-id-type="pmid">28776083</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>DS</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Zhang</surname><given-names>XF</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Fan</surname><given-names>GC</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy</article-title><source>Hypertension</source><volume>63</volume><fpage>713</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02653</pub-id><pub-id pub-id-type="pmid">24396025</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalucka</surname><given-names>J</given-names></name><name><surname>de Rooij</surname><given-names>LPMH</given-names></name><name><surname>Goveia</surname><given-names>J</given-names></name><name><surname>Rohlenova</surname><given-names>K</given-names></name><name><surname>Dumas</surname><given-names>SJ</given-names></name><name><surname>Meta</surname><given-names>E</given-names></name><name><surname>Conchinha</surname><given-names>NV</given-names></name><name><surname>Taverna</surname><given-names>F</given-names></name><name><surname>Teuwen</surname><given-names>L-A</given-names></name><name><surname>Veys</surname><given-names>K</given-names></name><name><surname>García-Caballero</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>Sokol</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Treps</surname><given-names>L</given-names></name><name><surname>Borri</surname><given-names>M</given-names></name><name><surname>de Zeeuw</surname><given-names>P</given-names></name><name><surname>Dubois</surname><given-names>C</given-names></name><name><surname>Karakach</surname><given-names>TK</given-names></name><name><surname>Falkenberg</surname><given-names>KD</given-names></name><name><surname>Parys</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Vinckier</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Fenton</surname><given-names>RA</given-names></name><name><surname>Schoonjans</surname><given-names>L</given-names></name><name><surname>Dewerchin</surname><given-names>M</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Bolund</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptome atlas of murine endothelial cells</article-title><source>Cell</source><volume>180</volume><fpage>764</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.01.015</pub-id><pub-id pub-id-type="pmid">32059779</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaiskos</surname><given-names>N</given-names></name><name><surname>Wahle</surname><given-names>P</given-names></name><name><surname>Alles</surname><given-names>J</given-names></name><name><surname>Boltengagen</surname><given-names>A</given-names></name><name><surname>Ayoub</surname><given-names>S</given-names></name><name><surname>Kipar</surname><given-names>C</given-names></name><name><surname>Kocks</surname><given-names>C</given-names></name><name><surname>Rajewsky</surname><given-names>N</given-names></name><name><surname>Zinzen</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The <italic>Drosophila</italic> embryo at single-cell transcriptome resolution</article-title><source>Science</source><volume>358</volume><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1126/science.aan3235</pub-id><pub-id pub-id-type="pmid">28860209</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>AL</given-names></name><name><surname>Shchukina</surname><given-names>I</given-names></name><name><surname>Amrute</surname><given-names>J</given-names></name><name><surname>Andhey</surname><given-names>PS</given-names></name><name><surname>Zaitsev</surname><given-names>K</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Bajpai</surname><given-names>G</given-names></name><name><surname>Bredemeyer</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Terrebonne</surname><given-names>E</given-names></name><name><surname>Rentschler</surname><given-names>SL</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Lavine</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-Cell transcriptomics reveals cell-type-specific diversification in human heart failure</article-title><source>Nature Cardiovascular Research</source><volume>1</volume><fpage>263</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/s44161-022-00028-6</pub-id><pub-id pub-id-type="pmid">35959412</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>P</given-names></name><name><surname>Christia</surname><given-names>P</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The pathogenesis of cardiac fibrosis</article-title><source>Cellular and Molecular Life Sciences</source><volume>71</volume><fpage>549</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1007/s00018-013-1349-6</pub-id><pub-id pub-id-type="pmid">23649149</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>BB</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Hoshi</surname><given-names>M</given-names></name><name><surname>Plongthongkum</surname><given-names>N</given-names></name><name><surname>Salamon</surname><given-names>D</given-names></name><name><surname>Knoten</surname><given-names>A</given-names></name><name><surname>Vijayan</surname><given-names>A</given-names></name><name><surname>Venkatesh</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Gaut</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2832</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10861-2</pub-id><pub-id pub-id-type="pmid">31249312</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Ai</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>Z</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ucp3 ablation exacerbates high-salt induced cardiac hypertrophy and cardiac dysfunction</article-title><source>Cellular Physiology and Biochemistry</source><volume>46</volume><fpage>1683</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1159/000489244</pub-id><pub-id pub-id-type="pmid">29694982</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Xiang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GDF11 attenuates development of type 2 diabetes via improvement of islet β-cell function and survival</article-title><source>Diabetes</source><volume>66</volume><fpage>1914</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.2337/db17-0086</pub-id><pub-id pub-id-type="pmid">28450417</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell RNA-seq reveals cellular heterogeneity of mouse carotid artery under disturbed flow</article-title><source>Cell Death Discovery</source><volume>7</volume><elocation-id>180</elocation-id><pub-id pub-id-type="doi">10.1038/s41420-021-00567-0</pub-id><pub-id pub-id-type="pmid">34282126</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Kassambara/ggpubr</data-title><version designator="swh:1:rev:63cd56663cda388ed76ddf8bfc0d4035c4b3eccd">swh:1:rev:63cd56663cda388ed76ddf8bfc0d4035c4b3eccd</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b9f6e0377eab921c2caadcac774d2ccd5abdb18d;origin=https://github.com/kassambara/ggpubr;visit=swh:1:snp:599f0682e4bd1a9b84b38ddb41d7b26e94dafc5d;anchor=swh:1:rev:63cd56663cda388ed76ddf8bfc0d4035c4b3eccd">https://archive.softwareheritage.org/swh:1:dir:b9f6e0377eab921c2caadcac774d2ccd5abdb18d;origin=https://github.com/kassambara/ggpubr;visit=swh:1:snp:599f0682e4bd1a9b84b38ddb41d7b26e94dafc5d;anchor=swh:1:rev:63cd56663cda388ed76ddf8bfc0d4035c4b3eccd</ext-link></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litviňuková</surname><given-names>M</given-names></name><name><surname>Talavera-López</surname><given-names>C</given-names></name><name><surname>Maatz</surname><given-names>H</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Worth</surname><given-names>CL</given-names></name><name><surname>Lindberg</surname><given-names>EL</given-names></name><name><surname>Kanda</surname><given-names>M</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Heinig</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Nadelmann</surname><given-names>ER</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Tuck</surname><given-names>L</given-names></name><name><surname>Fasouli</surname><given-names>ES</given-names></name><name><surname>DeLaughter</surname><given-names>DM</given-names></name><name><surname>McDonough</surname><given-names>B</given-names></name><name><surname>Wakimoto</surname><given-names>H</given-names></name><name><surname>Gorham</surname><given-names>JM</given-names></name><name><surname>Samari</surname><given-names>S</given-names></name><name><surname>Mahbubani</surname><given-names>KT</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Patone</surname><given-names>G</given-names></name><name><surname>Boyle</surname><given-names>JJ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Viveiros</surname><given-names>A</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Bayraktar</surname><given-names>OA</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Noseda</surname><given-names>M</given-names></name><name><surname>Hubner</surname><given-names>N</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cells of the adult human heart</article-title><source>Nature</source><volume>588</volume><fpage>466</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2797-4</pub-id><pub-id pub-id-type="pmid">32971526</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Jia</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hypoglycemic activities of A- and B-type procyanidin oligomer-rich extracts from different cinnamon barks</article-title><source>Phytomedicine</source><volume>18</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.08.008</pub-id><pub-id pub-id-type="pmid">20851586</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macosko</surname><given-names>EZ</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Nemesh</surname><given-names>J</given-names></name><name><surname>Shekhar</surname><given-names>K</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Bialas</surname><given-names>AR</given-names></name><name><surname>Kamitaki</surname><given-names>N</given-names></name><name><surname>Martersteck</surname><given-names>EM</given-names></name><name><surname>Trombetta</surname><given-names>JJ</given-names></name><name><surname>Weitz</surname><given-names>DA</given-names></name><name><surname>Sanes</surname><given-names>JR</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets</article-title><source>Cell</source><volume>161</volume><fpage>1202</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id><pub-id pub-id-type="pmid">26000488</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín-Juez</surname><given-names>R</given-names></name><name><surname>El-Sammak</surname><given-names>H</given-names></name><name><surname>Helker</surname><given-names>CSM</given-names></name><name><surname>Kamezaki</surname><given-names>A</given-names></name><name><surname>Mullapuli</surname><given-names>ST</given-names></name><name><surname>Bibli</surname><given-names>SI</given-names></name><name><surname>Foglia</surname><given-names>MJ</given-names></name><name><surname>Fleming</surname><given-names>I</given-names></name><name><surname>Poss</surname><given-names>KD</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Coronary revascularization during heart regeneration is regulated by epicardial and endocardial cues and forms a scaffold for cardiomyocyte repopulation</article-title><source>Developmental Cell</source><volume>51</volume><fpage>503</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.019</pub-id><pub-id pub-id-type="pmid">31743664</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name><name><surname>Davila-Velderrain</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>JZ</given-names></name><name><surname>Menon</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Abdurrob</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Martorell</surname><given-names>AJ</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Hafler</surname><given-names>BP</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>L-H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell transcriptomic analysis of alzheimer’s disease</article-title><source>Nature</source><volume>570</volume><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1195-2</pub-id><pub-id pub-id-type="pmid">31042697</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>MA</given-names></name><name><surname>Skelly</surname><given-names>DA</given-names></name><name><surname>Dona</surname><given-names>MSI</given-names></name><name><surname>Squiers</surname><given-names>GT</given-names></name><name><surname>Farrugia</surname><given-names>GE</given-names></name><name><surname>Gaynor</surname><given-names>TL</given-names></name><name><surname>Cohen</surname><given-names>CD</given-names></name><name><surname>Pandey</surname><given-names>R</given-names></name><name><surname>Diep</surname><given-names>H</given-names></name><name><surname>Vinh</surname><given-names>A</given-names></name><name><surname>Rosenthal</surname><given-names>NA</given-names></name><name><surname>Pinto</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>High-Resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy</article-title><source>Circulation</source><volume>142</volume><fpage>1448</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.045115</pub-id><pub-id pub-id-type="pmid">32795101</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Cha</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>EJ</given-names></name><name><surname>Jeong</surname><given-names>D</given-names></name><name><surname>Hajjar</surname><given-names>RJ</given-names></name><name><surname>Kranias</surname><given-names>EG</given-names></name><name><surname>Cho</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>WJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>AAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failure</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e43282</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0043282</pub-id><pub-id pub-id-type="pmid">22952658</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Cha</surname><given-names>H</given-names></name><name><surname>Oh</surname><given-names>JG</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Ginsburg</surname><given-names>KS</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>I</given-names></name><name><surname>Singh</surname><given-names>VP</given-names></name><name><surname>Wang</surname><given-names>HS</given-names></name><name><surname>Franzini-Armstrong</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>WJ</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Kranias</surname><given-names>EG</given-names></name><name><surname>Cho</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeted ablation of the histidine-rich Ca (2+) -binding protein (HRC) gene is associated with abnormal SR Ca (2+) -cycling and severe pathology under pressure-overload stress</article-title><source>Basic Research in Cardiology</source><volume>108</volume><elocation-id>344</elocation-id><pub-id pub-id-type="doi">10.1007/s00395-013-0344-2</pub-id><pub-id pub-id-type="pmid">23553082</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peet</surname><given-names>C</given-names></name><name><surname>Ivetic</surname><given-names>A</given-names></name><name><surname>Bromage</surname><given-names>DI</given-names></name><name><surname>Shah</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiac monocytes and macrophages after myocardial infarction</article-title><source>Cardiovascular Research</source><volume>116</volume><fpage>1101</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvz336</pub-id><pub-id pub-id-type="pmid">31841135</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Skibba</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II</article-title><source>Journal of Cellular and Molecular Medicine</source><volume>20</volume><fpage>482</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1111/jcmm.12763</pub-id><pub-id pub-id-type="pmid">26762600</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>BF</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Zhou</surname><given-names>JY</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>GS</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>YL</given-names></name><name><surname>Han</surname><given-names>DL</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>YG</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma</article-title><source>Cell Research</source><volume>29</volume><fpage>725</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/s41422-019-0195-y</pub-id><pub-id pub-id-type="pmid">31273297</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramilowski</surname><given-names>JA</given-names></name><name><surname>Goldberg</surname><given-names>T</given-names></name><name><surname>Harshbarger</surname><given-names>J</given-names></name><name><surname>Kloppmann</surname><given-names>E</given-names></name><name><surname>Lizio</surname><given-names>M</given-names></name><name><surname>Satagopam</surname><given-names>VP</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name><name><surname>Forrest</surname><given-names>ARR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A draft network of ligand-receptor-mediated multicellular signalling in human</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7866</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8866</pub-id><pub-id pub-id-type="pmid">26198319</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottlaender</surname><given-names>D</given-names></name><name><surname>Reda</surname><given-names>S</given-names></name><name><surname>Motloch</surname><given-names>LJ</given-names></name><name><surname>Hoppe</surname><given-names>UC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>New tyrosine kinase and EGFR inhibitors in cancer therapy</article-title><source>Der Internist</source><volume>52</volume><fpage>1245</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1007/s00108-011-2895-3</pub-id><pub-id pub-id-type="pmid">21792599</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Stubbington</surname><given-names>MJT</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The human cell atlas: from vision to reality</article-title><source>Nature</source><volume>550</volume><fpage>451</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1038/550451a</pub-id><pub-id pub-id-type="pmid">29072289</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudat</surname><given-names>C</given-names></name><name><surname>Norden</surname><given-names>J</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Kispert</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epicardial function of canonical Wnt-, hedgehog-, fgfr1/2-, and pdgfra-signalling</article-title><source>Cardiovascular Research</source><volume>100</volume><fpage>411</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvt210</pub-id><pub-id pub-id-type="pmid">24000064</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>I</given-names></name><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diabetes-Associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>90</volume><fpage>84</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.12.011</pub-id><pub-id pub-id-type="pmid">26705059</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schipke</surname><given-names>J</given-names></name><name><surname>Brandenberger</surname><given-names>C</given-names></name><name><surname>Rajces</surname><given-names>A</given-names></name><name><surname>Manninger</surname><given-names>M</given-names></name><name><surname>Alogna</surname><given-names>A</given-names></name><name><surname>Post</surname><given-names>H</given-names></name><name><surname>Mühlfeld</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification</article-title><source>Journal of Applied Physiology</source><volume>122</volume><fpage>1019</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00987.2016</pub-id><pub-id pub-id-type="pmid">28126909</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senatus</surname><given-names>L</given-names></name><name><surname>López-Díez</surname><given-names>R</given-names></name><name><surname>Egaña-Gorroño</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Daffu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Rahman</surname><given-names>K</given-names></name><name><surname>Vengrenyuk</surname><given-names>Y</given-names></name><name><surname>Barrett</surname><given-names>TJ</given-names></name><name><surname>Dewan</surname><given-names>MZ</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Fuller</surname><given-names>D</given-names></name><name><surname>Finn</surname><given-names>AV</given-names></name><name><surname>Virmani</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Friedman</surname><given-names>RA</given-names></name><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Ramasamy</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism</article-title><source>JCI Insight</source><volume>5</volume><elocation-id>e137289</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.137289</pub-id><pub-id pub-id-type="pmid">32641587</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheeran</surname><given-names>FL</given-names></name><name><surname>Angerosa</surname><given-names>J</given-names></name><name><surname>Liaw</surname><given-names>NY</given-names></name><name><surname>Cheung</surname><given-names>MM</given-names></name><name><surname>Pepe</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Adaptations in protein expression and regulated activity of pyruvate dehydrogenase multienzyme complex in human systolic heart failure</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2019</volume><elocation-id>4532592</elocation-id><pub-id pub-id-type="doi">10.1155/2019/4532592</pub-id><pub-id pub-id-type="pmid">30881593</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinagawa</surname><given-names>H</given-names></name><name><surname>Frantz</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages</article-title><source>Current Heart Failure Reports</source><volume>12</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1007/s11897-015-0255-7</pub-id><pub-id pub-id-type="pmid">25721354</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skelly</surname><given-names>DA</given-names></name><name><surname>Squiers</surname><given-names>GT</given-names></name><name><surname>McLellan</surname><given-names>MA</given-names></name><name><surname>Bolisetty</surname><given-names>MT</given-names></name><name><surname>Robson</surname><given-names>P</given-names></name><name><surname>Rosenthal</surname><given-names>NA</given-names></name><name><surname>Pinto</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptional profiling reveals cellular diversity and intercommunication in the mouse heart</article-title><source>Cell Reports</source><volume>22</volume><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.072</pub-id><pub-id pub-id-type="pmid">29346760</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>H</given-names></name><name><surname>Paylor</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>RW</given-names></name><name><surname>Lemos</surname><given-names>DR</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Arostegui</surname><given-names>M</given-names></name><name><surname>Low</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Fiore</surname><given-names>D</given-names></name><name><surname>Braghetta</surname><given-names>P</given-names></name><name><surname>Pospichalova</surname><given-names>V</given-names></name><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Rampazzo</surname><given-names>A</given-names></name><name><surname>MacLeod</surname><given-names>K</given-names></name><name><surname>Underhill</surname><given-names>TM</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pathogenic potential of hic1-expressing cardiac stromal progenitors</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>205</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.12.008</pub-id><pub-id pub-id-type="pmid">31978365</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speicher</surname><given-names>T</given-names></name><name><surname>Siegenthaler</surname><given-names>B</given-names></name><name><surname>Bogorad</surname><given-names>RL</given-names></name><name><surname>Ruppert</surname><given-names>R</given-names></name><name><surname>Petzold</surname><given-names>T</given-names></name><name><surname>Padrissa-Altes</surname><given-names>S</given-names></name><name><surname>Bachofner</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Koteliansky</surname><given-names>V</given-names></name><name><surname>Fässler</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3862</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4862</pub-id><pub-id pub-id-type="pmid">24844558</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stubbington</surname><given-names>MJT</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell transcriptomics to explore the immune system in health and disease</article-title><source>Science</source><volume>358</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1126/science.aan6828</pub-id><pub-id pub-id-type="pmid">28983043</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travers</surname><given-names>JG</given-names></name><name><surname>Kamal</surname><given-names>FA</given-names></name><name><surname>Robbins</surname><given-names>J</given-names></name><name><surname>Yutzey</surname><given-names>KE</given-names></name><name><surname>Blaxall</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cardiac fibrosis: the fibroblast awakens</article-title><source>Circulation Research</source><volume>118</volume><fpage>1021</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.306565</pub-id><pub-id pub-id-type="pmid">26987915</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>DD</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>LS</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrin β1D deficiency-mediated ryr2 dysfunction contributes to catecholamine-sensitive ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy</article-title><source>Circulation</source><volume>141</volume><fpage>1477</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.043504</pub-id><pub-id pub-id-type="pmid">32122157</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>RN</given-names></name><name><surname>Yu</surname><given-names>TY</given-names></name><name><surname>Zhou</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>HK</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>RQ</given-names></name><name><surname>Peng</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>ZW</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name><name><surname>Wu</surname><given-names>YQ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts</article-title><source>International Journal of Cardiology</source><volume>267</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2018.04.103</pub-id><pub-id pub-id-type="pmid">29957254</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshioka</surname><given-names>J</given-names></name><name><surname>Imahashi</surname><given-names>K</given-names></name><name><surname>Gabel</surname><given-names>SA</given-names></name><name><surname>Chutkow</surname><given-names>WA</given-names></name><name><surname>Burds</surname><given-names>AA</given-names></name><name><surname>Gannon</surname><given-names>J</given-names></name><name><surname>Schulze</surname><given-names>PC</given-names></name><name><surname>MacGillivray</surname><given-names>C</given-names></name><name><surname>London</surname><given-names>RE</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload</article-title><source>Circulation Research</source><volume>101</volume><fpage>1328</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.106.160515</pub-id><pub-id pub-id-type="pmid">17916779</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Zha</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Flos puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98044</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098044</pub-id><pub-id pub-id-type="pmid">24865768</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80479.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Balasubramanyam</surname><given-names>Muthuswamy</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00czgcw56</institution-id><institution>Madras Diabetes Research Foundation</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.06.29.498129" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.06.29.498129"/></front-stub><body><p>In this work, utilizing a murine model as well as in vitro studies, the authors provide novel insights about drivers of intercellular communication underlying pathological extracellular matrix remodeling during diabetic cardiomyopathy. The results of the study will be of interest to investigators interested in diabetic cardiomyopathy and heart failure as well as those looking for new potential targets in the treatment of heart failure.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80479.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Balasubramanyam</surname><given-names>Muthuswamy</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00czgcw56</institution-id><institution>Madras Diabetes Research Foundation</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Balasubramanyam</surname><given-names>Muthuswamy</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00czgcw56</institution-id><institution>Madras Diabetes Research Foundation</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Madeddu</surname><given-names>Paolo</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0524sp257</institution-id><institution>University of Bristol</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.06.29.498129">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.06.29.498129v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Single-Cell RNA-seq of Heart Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Muthuswamy Balasubramanyam as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Paolo Madeddu (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this letter to help you prepare a revised submission.</p><p>Essential revisions:</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The manuscript does have some limitations which need to be addressed via the review process. The study in its technical components and presentation are appropriate.</p><p>Comments:</p><p>1. Overall, the manuscript needs some improvement in results and discussion sessions. Authors are advised to discuss their results in consonance with the recent findings illustrated in the following recent important articles pertinent to the manuscript topic.</p><p>Koenig A.L. et al. 2022 (Nature Cardiovascular Research)</p><p>Ackers-Johnson et al. 2018 (Nature Communications)</p><p>2. Legends to the figures need to be shortened – as there is an overlap in the figure legends and the methodology section.</p><p>3. In the introduction, lines 78-88 should be deleted as the text context belongs to the Results section.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1) Figure2 S1: Please highlight some examples of what is displayed.</p><p>2) 2C and D: Please use the same color code for the panels.</p><p>3) 2F, G please label the y-axis.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The study is technically sound and well-illustrated. Some sentences need to be revisited. For instance, in the Introduction &quot;Since adult mammalian cardiomyocytes are virtually incapable of regeneration, the most extensive extracellular matrix remodeling and fibrosis of the heart occurs in diseases caused by acute cardiomyocyte death&quot;. Diabetes does not cause acute cardiomyocyte death.</p><p>In other points, associative findings are used to state a cause-relation effect or to highlight obvious concepts such as fibroblasts are important in fibrosis.</p><p>The study will take advantage of confirming the main data with the use of an additional mouse model. In addition, female mice should be included. The most important limit is represented by the fact the authors studied at a very late stage, these changes may not be the ones responsible for the final phenotype. A pseudotime analysis adding an early analysis of gene expression at a single cell level is mandatory.</p><p>Functional data are missing and histology is limited to fibrosis. What about capillary density and cardiomyocytes? Any effect on these cells by the used treatments? What about diastolic dysfunction? To understand whether the improvements are significant, an analysis by echocardiography is relevant.</p><p>The human data are not very useful. The association of diabetes with variants does not add to the experimental evidence provided on fibrosis. This part is weak and may be eliminated unless they provide evidence of an association with cardiac fibrosis or diastolic dysfunction.</p><p>General Recommendations for the authors:</p><p>The manuscript should be checked and corrected by a colleague whose first language is English. Also, the manuscript title should be changed from &quot;Single-Cell RNA-seq of Heart Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Mice&quot; to &quot;Single-Cell RNA-seq of Cardiomyocytes Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Cardiomyopathy&quot;.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80479.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The manuscript does have some limitations which need to be addressed via the review process. The study in its technical components and presentation are appropriate.</p><p>Comments:</p><p>1. Overall, the manuscript needs some improvement in results and discussion sessions. Authors are advised to discuss their results in consonance with the recent findings illustrated in the following recent important articles pertinent to the manuscript topic.</p><p>Koenig A.L. et al. 2022 (Nature Cardiovascular Research)</p><p>Ackers-Johnson et al. 2018 (Nature Communications)</p></disp-quote><p>Thank you very much for the comments of the reviewing editor. We have carefully read the paper recommended by the editor and have set forth these important revisions in the results and discussions section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2. Legends to the figures need to be shortened – as there is an overlap in the figure legends and the methodology section.</p></disp-quote><p>Thank you very much for the comments and suggestions of the editor. We have carefully revised the figure legends in the main text and updated the manuscript.</p><disp-quote content-type="editor-comment"><p>3. In the introduction, lines 78-88 should be deleted as the text context belongs to the Results section.</p></disp-quote><p>Thanks to the editor for the precious comments. We have deleted the lines 78-88 of the introduction in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1) Figure2 S1: Please highlight some examples of what is displayed.</p></disp-quote><p>Thanks to the reviewer for these comments. Details are as follow: Figure 2 is intended to give the reader a macroscopic view of the receptor and ligand expression patterns of different cell populations. More specific expression information can be seen in Supplementary file 6 and 7.</p><disp-quote content-type="editor-comment"><p>2) 2C and D: Please use the same color code for the panels.</p></disp-quote><p>Thank you very much for the opinion of the reviewer. We have remade Figure</p><p>2C and D according to your suggestion in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) 2F, G please label the y-axis.</p></disp-quote><p>Thank you very much for the comment of the reviewer. We have remade Figure 2F and G according to your suggestion in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The study is technically sound and well-illustrated. Some sentences need to be revisited. For instance, in the Introduction &quot;Since adult mammalian cardiomyocytes are virtually incapable of regeneration, the most extensive extracellular matrix remodeling and fibrosis of the heart occurs in diseases caused by acute cardiomyocyte death&quot;. Diabetes does not cause acute cardiomyocyte death.</p></disp-quote><p>Thank you very much for the comments of the reviewer. We have carefully read the introduction and revised the description according to your comments. Please refer to the newly submitted revised manuscript for specific revision.</p><disp-quote content-type="editor-comment"><p>In other points, associative findings are used to state a cause-relation effect or to highlight obvious concepts such as fibroblasts are important in fibrosis.</p><p>The study will take advantage of confirming the main data with the use of an additional mouse model. In addition, female mice should be included. The most important limit is represented by the fact the authors studied at a very late stage, these changes may not be the ones responsible for the final phenotype. A pseudotime analysis adding an early analysis of gene expression at a single cell level is mandatory.</p><p>Functional data are missing and histology is limited to fibrosis. What about capillary density and cardiomyocytes? Any effect on these cells by the used treatments? What about diastolic dysfunction? To understand whether the improvements are significant, an analysis by echocardiography is relevant.</p></disp-quote><p>Thanks to the reviewer for these precious comments. At your request, we have reinserted the DB/DB transgenic diabetic mice model and the female C57 mice in combination with high-fat-diet (HFD)/streptozotocin (STZ)-induced diabetes model. We found that the Pdgf(s)-Pdgfra axis remained activated in DB/DB and female C57 diabetic mice, and that the Hrc+ fibroblast subpopulation plays an important role in myocardial fibrosis. Finally, Ima treatment significantly inhibited Pdgfra</p><p>Phosphorylation, Pdgf(s)-Pdgfra interaction and collagen accumulation in transgenic DB/DB (Figure 7) and female C57 diabetic mice (Figure 8). Please see the revised manuscript for details.</p><p>In order to understand the improvement of heart function in diabetic mice after Ima treatment, we assessed the heart function of C57 diabetic mice by echocardiography, and the results showed that the heart function of mice was significantly improved after Ima treatment. Please check the specific results (Figure 3—figure supplement 5) in the main text of newly revised manuscript. At the same time, we also assessed myocardial hypertrophy by WGA staining (Figure 3—figure supplement 4), and the results showed that Ima treatment significantly inhibited myocardial hypertrophy in diabetic mice. The above validation experiments have fully revealed that Ima treatment can significantly inhibit myocardial fibrosis and improve cardiac function in diabetic mice. Therefore, Pdgf(s)-Pdgfra interaction and appearance of Hrc+ activated fibroblasts could be a common mechanism that promotes cardiac fibrosis in type II diabetes.</p><p>Finally, to investigate the transition of the fibroblast clusters in the mice heart, we applied single-cell trajectories analysis and showed that the cells formed a continuous progression, then progressively ending toward Hrc<sup>hi</sup> fibroblast, indicating that Hrc<sup>hi</sup> fibroblast may be a myocardial fibrosis-related cardiac fibroblast subpopulation (Author response image 1). Thanks again to the reviewer for these professional and precious comments.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Single-cell trajectories analysis.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80479-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>The human data are not very useful. The association of diabetes with variants does not add to the experimental evidence provided on fibrosis. This part is weak and may be eliminated unless they provide evidence of an association with cardiac fibrosis or diastolic dysfunction.</p></disp-quote><p>Thank you very much for the opinion of the reviewer. We have deleted the results of the association of Itgb1 variants with cardiac fibrosis. Thanks again to the reviewer for these professional comments.</p><disp-quote content-type="editor-comment"><p>General Recommendations for the authors:</p><p>The manuscript should be checked and corrected by a colleague whose first language is English. Also, the manuscript title should be changed from &quot;Single-Cell RNA-seq of Heart Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Mice&quot; to &quot;Single-Cell RNA-seq of Cardiomyocytes Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Cardiomyopathy&quot;.</p></disp-quote><p>Thanks to the reviewer for these kind comments. The revised manuscript has been checked by CureEdit to further improve the grammar and readability. At the same time, we have changed the title of the manuscript to &quot;Single-Cell RNA-seq of Heart Reveals Intercellular Communication Drivers of Myocardial Fibrosis in Diabetic Cardiomyopathy&quot; based on your comments. Thanks again to the reviewer for these precious and professional comments.</p></body></sub-article></article>